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EXPERIMENTAL IMMUNOLOGY AND THE POTENTIAL FOR 
OSTEOPATHOLOGICAL RECONSTRUCTIONS: 
PURSUING AN EXPERIMENTAL FOUNDATION FOR THE SKELETAL 
INFLAMMATORY INDEX 
Megan E. Duncanson  
April 12, 2019  
 
Individuals who mount a strong inflammatory response may produce a shift in the systemic 
levels of inflammatory mediators, which may lead to a potential hyper-inflammatory 
phenotype (HIP). Systemic inflammation can increase severity in local inflammatory 
processes detected in bone lesions. This thesis investigated in vitro if human immune cells 
pre-treated with inflammatory inducers would affect the inflammatory response against 
Porphyromonas gingivalis or Staphylococcus aureus (both associated with osteological 
lesions). We exposed human peripheral blood mononuclear cells to bacterial lysates, or 
pro-inflammatory cytokines. Sequentially, we exposed the same culture to either P. 
gingivalis or S. aureus. The final expression of TNFα and IFNγ was measured by ELISA. 
Our results showed that early exposure to the inflammatory inducers increased the 
expression of inflammatory cytokines. These findings could be useful in osteological 
analyses when considering how systemic inflammation may affect local inflammatory 
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The human skeleton provides a unique window into the past offering a glimpse of 
an individual long gone, even if no written records or other information remain. As such, 
understandings of health and disease in the past are often reliant on the osteological 
record as a primary source of evidence. Human skeletonized remains provide a wealth of 
information about that individual, their lifestyle, and in some instances, the diseases they 
carried (Larsen 2015). Still, despite the wealth of information that a skeleton can provide, 
there are limits. Physical abnormalities and lesions on bone do not necessarily reflect 
poor health in life, and recognition of this paradox exemplifies the necessity for careful 
consideration of what information the bones do provide (Wood et al. 1992). The very 
notions of what health and disease constitute are complex concepts, reliant on both 
specific biological and social contexts, as well as a broader evolutionary understanding of 
human history (Cohen 1989). However, utilizing different multidisciplinary perspectives 
can add necessary depth and nuance to what information can be taken away from the 
skeleton. These multidisciplinary perspectives allow for the potential synergistic 
interactions of multiple factors, such as environment or culture, to be taken into 
consideration in analyses of health in the past; a recognition of the complexities of health 
both past and present (Reitsema and McIlvaine 2014).  
 There are multiple etiologies of the diseases that present in the osteological 
record, and pathogens are not always the sole causative agents of lesions and 
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abnormalities detected on the bone. Stress, physical trauma, or even mechanisms of the 
human body itself may create or contribute to what is observed in the osteological record 
(DeWitte and Stojanowski 2015). Inflammation, one of the fundamental processes of the 
immune response, is not only capable of causing tissue damage, but may also exacerbate 
other underlying causative processes of tissue damage, including that of bone alteration 
(Abbas et al. 2015). Therefore, in order to contextualize and better understand what 
information the osteological record does provide, it is necessary to understand the context 
of the bone during life, that is, the context in which those lesions and abnormalities 
formed.  
 The immune system is both a defense and a maintenance mechanism. Its 
complexity allows for a flexible and varied response to disease, yet these same protective 
mechanisms can also contribute to tissue damage and pathological consequences. The 
entire system is a balancing act: deficient immune responses allow for increased 
susceptibility to further encroachments from pathogens, while excessive responses may 
result in harm to the individual and compromise subsequent immune responses. The 
skeletal record represents those deceased, yet understanding the mechanisms of immune 
function, how inflammation manifests, and the consequences of such in life are still 
relevant to further osteological analyses (Crespo et al. 2017). Highlighting the myriad 
complexities of health, considerations of immune function are increasingly pertinent for 
broader analysis of bone.   
Given the complexity of the biological context of bone, application of a 
combination of assessments afforded by different disciplines creates a more nuanced end 
perspective. Related, yet diverse fields of study may provide new insights regarding the 
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paradoxical evidence of health observed in the skeletal record. Here, in addition to an 
overview of the immune system and inflammation, the potential insights of experimental 
immunology, osteoimmunology, archaeoproteomic analysis, and paleopathology will be 
briefly considered. However, the potential perspective that experimental immunology 
specifically may add to bioarchaeological considerations regarding the role of 
inflammation, as part of larger multidisciplinary reconstructions of health and stress from 
the osteological record, will be considered as the primary, and necessary, starting point 
for this line of inquiry.  
Immunology: A starting point for inquiry 
 In order to consider what evidence experimental immunology may contribute to 
bioarchaeological considerations, a review of what experimental immunology is, and 
more important foundationally some of the basics of immunology, is warranted to 
provide necessary context for understanding inflammation. Immunology is the study of 
the immune system, a complex network of organs and cellular components that work 
together to maintain the homeostatic balance while protecting an individual from insults, 
mainly pathogens. A pathogen is defined as “any agent capable of causing infection or 
disease in a cell or organism” (Karp 2009). It is important to note that pathogens are not 
exclusively bacteria. Historically, immunity referred to the protection from disease, 
specifically infectious disease, but noninfectious foreign substances, and even products of 
the body itself can elicit an immune response (Abbas et al. 2015). The immune system 
itself is not a singular entity: it is a complex network of systems (including organs, 
tissues, and cellular components) that work in concert to elicit a response. This inherent 
complexity allows for an overall flexible response depending on the insulting stimulus. 
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This system functions as a whole but can be understood as two large complementary and 
overlapping systems; innate immunity and adaptive, or acquired, immunity.  
 Innate immunity can be thought of as the first line of defense for an individual. 
The adaptive immune response requires time, so the effector mechanisms of innate 
immunity clear out, or at least hold off the infection until the acquired response is ready 
(Abbas et al. 2015). Detection of a pathogen elicits a rapid response in which these 
effector mechanisms recognize foreign molecular structures that set apart bacteria and 
other pathogens from human cells. The innate system recognizes broad groups of 
conserved structures (pathogen-associated molecular patterns), rather than with the 
specificity that characterizes the adaptive response (Medzhitov and Janeway 2000). 
Players on the innate side of immunity include the phagocytic cells (macrophages and 
neutrophils), as well as a system of blood proteins and chemical mediators that comprise 
the complement system (Abbas et al. 2015). These innate reactions are generally not 
specific, and the same responses are elicited regardless of the stimulus. The innate 
response works quickly to neutralize and eliminate the insult, preventing further survival 
or encroachment of the pathogen. In addition to the traditional understandings of innate 
immunity as the initial pathogen response, the innate system also works to help control 
the adaptive response (Medzhitov and Janeway 2000). These two systems do not function 
in isolation from one another, and mechanisms of one system, such as complement, are 
increasingly recognized as bridging the innate and adaptive immune responses 
(Markiewski and Lambris 2007). 
 Although innate immunity evolved first, it has its limitations. Not every pathogen 
is eliminated by this initial response. The scope of recognition of innate immunity is 
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limited, and the ability of pathogens to mutate or otherwise avoid detection spurred the 
development of the adaptive side of immunity (Bonilla and Oettgen 2010). Adaptive 
immunity generates a specific response to each pathogenic insult via highly variable 
recognition receptors on adaptive cells. This system can recognize a wide variety of 
insults and even has the ability to recognize specific pathogens encountered previously, 
creating an immunological memory that allows for a much faster response time upon 
reinfection (Bonilla and Oettgen 2010). However, this process is not instantaneous, and it 
can take from several days up to a full week for this system to effectively mount a 
response (Abbas et al. 2015). The adaptive response can be broken down into two major 
categories: humoral immunity which utilizes B lymphocytes and antibody production, 
and cell-mediated immunity mediated by T lymphocytes, which generally target infected 
cells. These lymphocytes are mobile and traffic to infected areas upon recruitment by 
innate immune signals.  
 The two arms of the immune system must be able to communicate with one 
another and do so via chemical mediators, cytokines. Cytokines are proteins produced 
and secreted by a variety of cells, and are the primary mediators of the immune system 
(Abbas et al. 2015). There is tremendous diversity in cytokines and their functions, and 
many effector functions of such depend on context. Individual cytokine function can vary 
depending on the type of cell producing it and its microenvironment (Turner et al. 2014). 
For example, the role of localized cytokines in a microenvironment which are indicative 
of either a type I or type II response, are a reflection of which effector T cells are 
operating within that specific context. In addition, the production of cytokines in and of 
themselves can alter the functional states of the targeted tissues and organ systems 
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(Abbas et al. 2015). Cytokines are of particular interest when considering inflammation, 
as these ubiquitous proteins are a fundamental part of the overall immune response, with 
effector and regulatory functions across both innate and adaptive responses (Abbas et al. 
2015; Turner et al. 2014). Specific cytokines IL-1β, TNFα, and IFNγ are of particular 
interest for their proinflammatory roles and implications for the human skeleton.  
As a complex whole, diverse mechanisms from both innate and adaptive 
immunity can influence one another and even subsequent immune responses. However, a 
full review of the intricacies of the immune system is well beyond the scope of this 
project. Instead, focus will be given to one of the most important aspects of the immune 
response, inflammation, specifically because the consequences of elevated or 
pathological inflammation may contribute to abnormalities observed in the osteological 
record. Inflammation does not exist in a vacuum, and increasingly the consequences of 
the inflammatory response must be addressed in the context of osteological 
interpretations, as inflammation has a direct impact on bone physiology (Crespo et al. 
2017; Hardy and Cooper 2009; Klaus 2014; Redlich and Smolen 2012).  
Inflammation  
A familiar process accompanying injury and sickness, the first to describe the 
hallmark clinical symptoms of inflammation (redness, swelling, heat, and pain) was 
Cornelius Celsus in the 1st century CE (Medzhitov 2010). Specifically, it is the 
recruitment and accumulation of leukocytes and plasma proteins at a specific site of 
infection or tissue injury for purposes of containment and control (Soehnlein and 
Lindbom 2010). The extravasation of leukocytes out of circulation and towards the site of 
the infection or injury, and their subsequent work there to neutralize and eliminate the 
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problem, produces these standard clinical symptoms (Ashley et al. 2012). Both the arms 
of the immune system utilize inflammation, but the local, acute inflammatory response is 
the hallmark of innate immunity, developing in as little as a few minutes and capable of 
persisting for days (Abbas et al. 2015). Organ systems are linked via intricate cellular 
pathways trafficked by the specialized immune cells and chemical mediators (cytokines 
and chemokines) at both the local and systemic level, and inflammation as a whole can be 
thought of broadly as “…a system of information flow in response to injury and 
infection” (Nathan 2002).  
The inflammatory response can be conceptualized as moving through a series of 
checkpoints, with multiple factors built in to prevent inappropriate escalations of the 
inflammatory response (Ashley et al. 2012; Nathan 2002). This response can be 
understood in terms of inducers and mediators of inflammation: inducers are signals that 
initiate the response, such as a pathogen, while mediators are the effectors of the response 
(cytokines). The production of these mediators alters the functional state of the targeted 
tissue and organs systems and while it remains unclear whether the nature of the inducer 
influences the production of a specific mediator, in general, inflammatory mediators 
often induce the production of additional mediators, escalating the inflammatory response 
(Abbas et al. 2015; Medzhitov 2008). Initially local, inflammation is triggered by some 
noxious stimulus that includes a “tissue-based startle reaction to trauma”, which sets into 
motion recruitment of cells to deal with the stimulus (Nathan 2002). However, the very 
cytokines that orchestrate an inflammatory event may contribute to inappropriate 
inflammation later if concentrations are increased, regulatory mechanisms fail, or even 
the population of cells transitions away from neutrophils to macrophages (Ashley et al. 
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2012; Medzhitov 2008; Turner et al. 2014). The extent of influence inflammatory 
mediators have extends beyond the immediate site of inflammation: when these 
mediators induce the formation of an exudate there are additional effects on the 
associated neuroendocrine and metabolic functions of the targeted tissue, as well as 
maintenance of tissue homeostasis in general (Ashley et al. 2012; Medzhitov 2008). 
Every step of the inflammatory process should be tightly regulated by multiple checks 
and balances on the system. However, the lack of inflammation is not a passive absence 
of inflammatory stimuli; rather, the maintenance of health requires checkpoints that 
suppress inappropriate inflammatory reactions (Nathan 2002).  
Inflammation is a dynamic process and can be understood in the context of both 
duration and location. Failure to resolve the initial crises, or failure of the immune system 
to resolve the initial inflammation, shifts the acute response to a chronic one (Ahmed 
2011; Ashley et al. 2012). Furthermore, just as acute can become chronic it is possible for 
local events to become systemic. When leukocytes secrete cytokines in response to 
bacterial products this also stimulates the production of acute-phase proteins, leading to 
systemic manifestations of the local event (Abbas et al. 2015). The process of spillover is 
the overflow of excess proinflammatory cytokines (including TNFα and IL-1β) and 
inflammatory mediators (activated immune cells and proteins) from the initial local site 
and out into circulation (Ashley et al. 2012). The subsequent activation of sensory nerves 
from this spillover report inflammation to the entire body (Straub 2011). This type of 
spillover process is often concomitant with cytokine storms, the abnormal and often 
pathological increase in cytokine signaling and production (Tisoncik et al. 2012). 
Cytokine storms can increase the severity of the inflammation as well as the duration, 
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often more so than the spillover observed in peripheral blood (Tisoncik et al. 2012). 
However both cytokine storms and spillovers have systemic consequences in terms of the 
severity of the continuing inflammatory response, as well subsequent immune reactions 
(Crespo et al. 2017). 
While systemic inflammation does not necessarily have to be chronic it often is, 
and highlights the point that inflammation is not one singular uniform process. 
Conceptualizing inflammation as “a diverse range of inflammations”, or a diverse range 
of the inflammatory response, may be more useful than considering inflammation as a 
single entity (Ahmed 2011; Ashley et al. 2012). Initiated by numerous stimuli and 
regulated by differing mechanisms inflammation is highly variable: indeed the 
characteristics of chronic inflammation even differ simply depending on which effector 
class of T cell is present (Medzhitov 2008). Likewise, local microenvironments exert 
influence on the inflammatory response when immune cells interact with local cells 
comprising the tissues of the organs experiencing the inflammatory infiltrate (Libby 
2007). Aberrant expression of adhesion molecules in these microenvironments 
subsequently leads to inappropriate leukocyte retention and survival in tissues. For 
example, fibroblasts, once thought to provide structural support to tissues, are 
increasingly implemented in active contribution to the retention and persistence of the 
inflammatory response (Buckley 2011). In addition, fibroblasts themselves appear to be 
modified by local inflammation highlighting the inherent complex give and take of any 
immune response, and consequently how pathological responses may quickly compound 
into chronic situations (Buckley 2011).  
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Even processes that have not been traditionally considered inflammatory are 
increasingly being recognized as playing a role in inflammation, such as with the 
activation of the complement system. Here the formation of an enzyme complex with 
proteolytic activity leads to the lysing of the targeted cell. This serves to highlight that 
different parts of an enormously complex system can contribute to inflammation 
(Markiewski and Lambris 2007). While classical infection-inflammatory pathways are 
well elucidated, other inflammatory processes are not as much, and with such inherent 
variability it is becoming apparent that the mechanisms of much of sustained 
inflammation, especially states of systemic chronic inflammation, are poorly understood 
(Ahmed 2011; Ashley et al. 2012; Medzhitov 2008). It is important to remember the 
complexities inherent to the immune response in subsequent considerations of 
inflammation. As the pathogenesis of diseases are increasingly recognized as 
heterogeneous, so too is inflammation (Straub 2011).  
Inflammation as a double-edged sword: Consequences of hyperinflammation  
It is a paradox then that one of the fundamental processes of the immune response 
meant to protect an individual can in turn become detrimental, and inflammation 
exemplifies a double-edged sword. The shift from the acute local response to the chronic 
systemic one is of particular interest as in general it is chronic systemic inflammation that 
is implicated in states of chronic disease and subsequent pathological immune responses 
(Ahmed 2011; Medzhitov 2008). Indeed, “the pathological potential of inflammation is 
unprecedented for a physiological process” (Medzhitov 2008). One function of 
inflammation is to clear damaged cells and initiate tissue repair in response to injury 
(Soehnlein and Lindbom 2010). Characterized by the influx of cells to the local site of 
11 
 
injury, this process becomes pathological with dysregulation of the normal resolution 
mechanisms (Libby 2007; Medzhitov 2010). The mechanisms of efficient removal of 
pathogens and apoptotic cells, that is, the utilization of reactive oxygen species, cytokines 
and other inflammatory mediators, in turn damage host tissues with prolonged exposure 
(Libby 2007). Individuals are not immune to their own inflammation, and failure to 
resolve the response, or prolonged exposure to the potent molecular components of the 
inflammatory response, can be quite harmful to the individual (Ashley et al. 2012).   
 Dysregulation of control mechanisms leads to pathology, and so too do 
inappropriate responses to pathogens or other insults. Cytokine spillover opens the door 
to systemic consequences of initial inflammatory responses: indeed, chronic 
inflammatory diseases are systemic in their very nature (Straub 2011). Regulation of 
inflammation is not passive, it takes active regulation to avoid an overreaction to minimal 
threats (Nathan 2002). Signaling pathways in essence program for normal self-limitation 
and termination in the very initial phase of the activation of the acute inflammatory 
response (Serhan and Savill 2005). Even specific cells play a part in resolution: 
leukocytes have the ability to trigger a self-limiting response in acute inflammation, and 
neutrophils undergo increased rates of apoptosis after certain time points (Serhan and 
Savill 2005; Soehnlein and Lindbom 2010). These self-limiting responses help to 
facilitate resolution as clearance of the initial inflammatory cells helps to terminate the 
inflammatory response.  
Active events in early signaling pathways as well as continuous checkpoints 
throughout the development of the entire inflammatory response are crucial for normal 
functioning, and any dysregulation at any point along these pathways has the potential to 
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influence downstream events (Nathan 2002; Serhan and Savill 2005). Indeed, any 
dysregulation in the balance of pro-and-anti-inflammatory mechanisms may contribute to 
the development of cytokine storms (Tisoncik et al. 2012). Furthermore, the 
establishment of positive feedback loops quickly escalates the inflammatory response. 
Increasingly chronic inflammatory conditions are described where the initiating trigger 
(injury, pathogen) is undefined, yet the escalation and positive feedback loops are present 
(Medzhitov 2010). Dysregulation in pathways necessary for control of inflammation may 
be responsible for some of these chronic situations where the stimulating trigger is 
unknown (Nathan 2002). Dysregulation is increasingly recognized more in the 
underlying etiology of chronic inflammatory conditions, and while multiple layers of 
regulatory safeguards exist to check against pathological consequences, these are not 
always failsafe (Barton 2008; Medzhitov 2010). Indeed, with signaling pathways so 
responsive that distinct inflammatory outcomes may depend in part on which specific 
type of ligand is recognized, let alone the context in which that ligand is recognized, it is 
important to keep in mind the myriad complexities of inflammation as a whole (Barton 
2008). 
Keeping these myriad complexities of inflammation as a whole in mind is also 
necessary to provide bioarchaeological considerations of inflammation proper context. 
With the pathological consequences of inflammation regardless of the etiology that 
spurred an inflammatory response, it is important to keep in mind the potential effects on 
bone that sustained inflammation may exert (Redlich and Smolen 2012). The 
consequences of inflammation are important to osteological questions, as chronic 
inflammatory disorders are often associated with bone loss and remodeling (Hardy and 
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Cooper 2009). Considering these pathways and their cellular components provides 
context to better frame questions that relate to both immunology and bone.  
Homeostasis, energy, and sustained inflammation  
The mechanisms of inflammation and the function of the immune system as a 
whole should also be considered within the larger context of the entire body. How 
inflammation is sustained, and how it relates to the body functioning as a whole is 
necessary background to understand how in turn inflammation will relate to and influence 
bone. The immune response is implicated in more than just pathogen responses: it also 
plays an important role in maintaining homeostasis (as well as extending and 
complementing homeostatic capacity) and overall stress responses of the body 
(Chovatiya and Medzhitov 2014; Medzhitov 2008). Broadly, when homeostasis is 
disrupted a stress response is mounted, and if this is insufficient to restore homeostasis, 
then an inflammatory response is induced (Chovatiya and Medzhitov 2014). 
Immunological homeostasis as evident in the adaptive arm of the immune system, 
contributes to homeostasis by controlling the expansion and contraction of the immune 
response, especially in regards to the resolution of inflammation (Abbas et al. 2015; 
Andersson and Tracey 2012). 
The maintenance of homeostasis occurs at multiple levels (systemic; tissue; 
cellular) and helps to maintain the organism at an acceptable and stable range, tightly 
regulated by the endocrine and autonomic nervous systems, although immunity and the 
immune response has long been considered an autonomous response to stimuli, separate 
from the regulations of the rest of the body (Andersson and Tracey 2012; Chovatiya and 
Medzhitov 2014). Yet increasing evidence shows that the immune system is functionally 
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and anatomically connected to the nervous system, with systemic implications for the 
regulation of the immune response. Nerve endings have been found nanometers away 
from immune cells that happen to express receptors for primary neurotransmitters: 
anatomically pointing to the communication possible between the two systems 
(Andersson and Tracey 2012). The connectedness of these systems is of interest as 
neuroendocrine regulation may help to explain both the control and the maintenance of 
inappropriate inflammation, such as in the absence of injury or disease. With the 
recognition that behavior, mental illnesses, and even chronic psychological stress are 
often accompanied by chronic smoldering inflammation, it is necessary to consider the 
role of the neuroendocrine system in factors of chronic inflammation (Padro and Sanders 
2014; Straub 2011). The vagus nerve serves as a highway for hormones and molecular 
products of the immune system to communicate with the brain, and lesions (anatomical, 
functional, or molecular) in such are associated with enhanced cytokine production 
observed in non-resolving inflammation (Andersson and Tracey 2012). In addition, close 
interactions between the cytokine system as a whole and the endocrine system exemplify 
the reciprocal relationships between mediators that may come into play, influencing 
disease progression and prognosis (van der Poll et al. 1994). The importance of the 
communication between these systems becomes apparent with pathological consequences 
of disruptions in these signaling pathways, and even though a disruption may be short 
term, the health consequences can become chronic, and due to the bidirectional nature of 
this relationship, one system can influence the other (Padro and Sanders 2014). This is 
one such context in which inappropriate inflammation may manifest, leading to systemic 
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consequences (such as observed in the osteological record), without pathogens or injury 
present.  
One of the most important aspects of homeostatic control is energy regulation, 
especially considering that the immune system is one of the top three consumers of 
energy, including the brain and muscular system (Straub 2014; Straub et al. 2010). Much 
of inappropriate systemic inflammation can be considered within the context of energy 
regulation. An increase of inflammatory cytokines at even low serum levels can induce 
an energy reallocation program, funneling fuel to an activated immune system (Straub 
2011). This is an important consideration as the activated immune system is costly, 
consisting of up to 25% of the basal metabolic rate (Straub et al. 2010). Yet the utilization 
of these energy stores can come at a cost, especially when bone is used to support 
immune function. Higher incidences of multiple bone fractures are correlated with an 
increase in the metabolic rate by 15-30% (Straub et al. 2010). Bone is a repository of 
calcium and phosphorous, and retrieval of this energy comes at a cost to bone: even low 
grade chronic inflammation is associated with a decrease in bone quality (van Niekerk et 
al. 2018). The utilization of bone initially makes sense, as it is a quick source of 
phosphate (necessary for effector cell function) and calcium (necessary for cell survival) 
(van Niekerk et al. 2018). In cases of severe disease, calcium is only provided from 
boney sources, not from the intestine (Straub et al. 2010). Vitamin D is a major hormone 
for the storage of calcium and phosphorous in bone, and bone remodeling is a direct 




Like most bodily systems homeostasis is not discrete and “inflammation can be 
viewed as the end of the spectrum of mechanisms that maintain and defend homeostasis” 
(Chovatiya and Medzhitov 2014). However, existing on a spectrum, it is possible for a 
shift to occur in the relevant set points of homeostasis so that they become reset, in that 
the abnormal becomes the new normal (Medzhitov 2008). For whatever underlying 
reason, in this context chronic inflammation becomes the new set point, and while this 
inflammation is of a lesser magnitude than the stereotypical acute inflammatory response, 
it still occurs at the expense of other physiological processes, and a decline in function in 
affected areas (Medzhitov 2008). That is, for any disruption in homeostasis, there should 
be a corresponding stress response, and if this fails to restore the system, inflammation is 
induced (Chovatiya and Medzhitov 2014). Stress responses are thorny, as the 
implementation of inflammation can be both in response to stress, as well as a defense 
mechanism of the system. That is not to say stress is always bad, rather it is an 
evolutionary response, and under certain conditions stress may prep and even enhance the 
immune system for upcoming stressors (Dhabhar 2014). It is the dysregulation of the 
response to stress that helps to create the physiological environment of inappropriate and 
sustained inflammation. A more nuanced approach may be to consider stress and 
subsequent responses in terms of allostatic loads, with high loads resulting in 
dysregulation or suppression of immune function (Dhabhar 2014). 
The evolutionary context: Why does this happen? 
Placing inflammation in a larger evolutionary context helps to clarify why 
pathological inflammation exists, as well as how to recognize when and why this might 
happen. The immune system is a powerful system, but one influenced by the brain and 
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constrained by limits on available energy. The evolutionary perspective seeks to 
contextualize observed phenomena, such as sustained inflammation, within the long-term 
perspective of our species. This broad view elucidates the why for some responses that 
are not immediately apparent. It is likely that inflammation evolved as an adaptive 
response for restoring homeostasis, and the immunoenhancement observed during acute 
stress is part of this adaptive response (Ashley et al. 2012; Dhabhar 2014; Medzhitov 
2008). This does not appear unique to mammals either, as evidence that neural circuits 
have coevolved with, and influenced the evolution of such, at least as far back as the 
invertebrate period (Andersson and Tracey 2012). Yet sustained inflammation exerts a 
costly and overall negative effect on reproductive fitness.  
 Inflammation triggered by noxious stimuli is generally a short-term response, and 
the homeostatic networks between the neuroendocrine system and the immune system 
came under positive selection for the benefits related to survival and increased fitness 
from short term, yet strong, inflammatory responses (Straub and Schradin 2016). This 
response is mounted at the expense of other physiological processes, so therefore it 
cannot be sustained for an extended period without detrimental consequences to the host 
(Medzhitov 2008). The acute inflammatory response has come under selection for the 
rapid resolution of infection, with a general time frame that corresponds with that of 
germinal center B cell expansion and contraction of approximately 21-28 days (Straub 
and Schradin 2016). Longer responses take a toll on fitness, so there exists a dilemma 
between the needs of the active immune system and the rest of the body, yet short-lived 
inflammation increases fitness (Straub and Schradin 2016). Beyond set time limits of 
acute inflammation (lasting anywhere from 21-60 days broadly), regulation and 
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resolution of inflammation fails after this time, as it falls beyond the limits of adaptedness 
(Straub et al. 2015). Consuming infectious diseases may run through available energy 
stores (capped around 43 days), so limits on energy availability can help explain the 
relatively constant course of adaptive immune responses and define the point of transition 
to chronic disease at the time point of complete energy consumption (Straub 2012). 
The pathological potential of inflammation is unprecedented for a physiological 
process (Medzhitov 2008). It is a paradox that a beneficial response can also be so 
damaging. Evidence of such damage, such as observed in bone, is contextualized by the 
evolutionary perspective. The use of phosphate from bone resorption is evolutionarily 
conserved to sustain the biosynthetic activities of activated immune cells, a phenomenon 
also observed in multiple species, indicative of an evolutionary conserved immune 
response (van Niekerk et al. 2018). The use of bone for energy is not a coincidence; use 
of bone has been selected for in acute responses and it is only in chronic situations that 
the use of bone becomes pathological (Straub et al. 2015). In addition, as part of sickness 
behavior, the decrease in mobility also stimulates bone loss, feeding energy to the system 
(Straub et al. 2015).  
The neural circuits that regulate immunity evolved in response to products of the 
immune system formed in response to infection and injury (Andersson and Tracey 2012). 
Yet these same neural pathways selected for in regard to acute inflammation are the same 
implicated in chronic inflammatory diseases (Straub 2014; Straub and Schradin 2016). 
“The potential of chronic development increases with the number of erroneous 
adaptational reactions…” or, the accumulation of inappropriate uses of those conserved 
pathways contribute to pathological inflammation (Straub and Besedovsky 2003). In 
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addition, long standing use of neuroendocrine pathways is in of itself a disease 
aggravating etiologic factor (Straub 2014). This makes sense, as the evolution of the 
immune response is heavily tied to energy regulation and homeostatic regulation. 
 Energy concerns are not the only selective pressure in play, and it should be 
briefly mentioned that the immune response also reflects the inherent reactivity of the 
system as a whole, one shaped by evolutionary forces to keep pace with pathogens and 
their immunoevasive and immunosuppressive maneuvers (Graham et al. 2005). Indeed, 
pathogens may be a contributing and even causal factor in chronic inflammatory diseases. 
Mycobacteria species especially are well supported candidates for pathogen-mediated 
selection altering inflammatory pathways, and increasing the frequency of chronic 
disease alleles in humans (Brinkworth and Barreiro 2014). Pathogen interactions may 
modulate the host immune response towards immunopathological responses, all in an 
attempt to eliminate the pathogen (Graham et al. 2005). Increasingly, progress of an 
infection is a function of pathogen load and the virulence of a particular strain (Gluckman 
et al. 2009). The role of pathogen survival contextualized by the mechanisms of the 
immune response may help to better understand some of the pathological responses of the 
host immune system. The long-term arms race between pathogen and host has no end in 
sight, and this may help to frame considerations of inappropriate inflammation and 
subsequent consequences moving forward.  
Searching for an inflammatory phenotype 
Bone is biologically complex, and investigations of such from the 
bioarchaeological record would do well to consider the inflammatory response. The shift 
from local to systemic, from short term to chronic, and the implications in terms of 
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impact on the type of, and severity of the inflammatory response, and in turn the potential 
impact on bone, must be addressed in these bioarchaeological interpretations (Crespo et 
al. 2017; Klaus 2014). Given the inherent complexity of the immune system as briefly 
reviewed above it is no surprise that there exists significant heterogeneity and variability 
of the immune response to disease in any given population. Yet it is not always possible 
to study complete populations in the past. Nonetheless, individuals can provide a great 
source of information. How well an individual can response to various insults and the 
ability of the immune system to generate an appropriate response to an insult comprises 
an individual’s immune competence (IC) (Crespo and Lawrenz 2014). 
 Immune competence is an important concept: it is a reflection of the immune 
system’s responsiveness, including both innate and adaptive functions. It reflects the 
balancing act of maintaining homeostasis, as excessive or deficient responses are 
pathological. While competence is maintained by the cellular and chemical mediators of 
the overall system, the competence of an individual is more than just a tally of cell count 
and type: immune competence is a reflection of an individual’s evolutionary history, as 
well as their environment, both physical and social. The complex interplay of these 
factors shapes the reactiveness of the system as a whole, with moving pieces comprising 
an individual’s immune competency. This competence is a reflection of the individual 
and is not merely the ability of the body to mount an immune response. Competence here 
is a reflection of function and individual life history and context.  
As neither populations nor individuals are fixed entities, immune competence can 
shift over an individual’s lifetime as their environment, biological or social, changes 
(Crespo and Lawrenz 2014). Heterogenous environments are comprised of varied 
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challenges and stresses that stimulate the immune system. The presence of comorbidities 
or even subsequent exposures to additional pathogens may elicit an inappropriate 
response depending on an individual’s environment. Indeed, this type of 
immunomodulation is grounded in the environments encountered in infancy and early 
childhood; these early environments shape an individual’s immunophenotype, one that is 
modified over the course of the individual’s lifespan (McDade 2012). Given the 
interconnectedness of systemic responses factors such as diet or even social and 
psychological stress can influence the immune response (Dantzer et al. 2008; Dhabhar 
2014; McDade 2012). Stress is one such factor that has been implicated in systemic 
inflammation, associated with the dysregulation of the stress response and high allostatic 
loads (Dhabhar 2014). Moreover, the examination and redefinition of the role of stress in 
analyses of health needs to be incorporated into analyses of the immune response; 
relevant here for contextualizing both the individual inflammatory response 
(competence), as well as for osteological analyses (Dhabhar 2014; Temple and Goodman 
2014). 
Yet it is important to emphasize that immune competence is not a purely 
biological concept (Crespo and Lawrenz 2014). Humans are complex biosocial creatures, 
that is to say, influenced by both our genes and culture, and as such cannot be removed 
from environments framed and shaped by culture and society. In addition, human biology 
and human beings cannot be reduced to only biological processes: people are the product 
of complex dialectical relations between biology and culture, and there is an inextricable 
connection between the two (Goodman 2013; Larsen 2015). Taking our biosocial 
environment into consideration is necessary to contextualize the how and the why of the 
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potential immune system reaction to certain or even perceived threats. Moreover, while 
all people share the same fundamental components of the immune system, the same 
cellular players and pathways, the responses of such that comprise competence are highly 
variable and dependent on individual context: that is, individual life histories and 
environments (McDade 2012). Furthermore, as the immune system is so plastic, it stands 
to reason that events early in life, if not in utero, can shape later immune responses as 
well as the long-term inflammatory phenotype (McDade 2012; McDade et al. 2010). This 
idea of “immunological plasticity”, that is the capacity to adjust or modify responses 
depending on intra-or-extra-cellular conditions, also helps to frame the idea of the 
variability and flexibility of the immune system over time (Crespo and Lawrenz 2014).  
Inflammation is the hallmark response of the immune system and as such is an 
important part of immune competence. Due to its potent capabilities and systemic reach, 
it is also the one immune response most likely to inadvertently cause damage to the host. 
Its dual function of defense and tissue repair can quickly become pathological with 
dysregulation and failure of systemic checks to control the response. An individual’s 
inflammatory response, as a component of competence, comprises the inflammatory 
phenotype (IP), shaped extensively by individual biosocial contexts and life history 
(McDade 2012). Thus, the inflammatory phenotype provides clues to how the individual 
may react to stressors, informed by specific environmental contexts.  Within this 
biosocial context then, those individuals who mount a stronger initial inflammatory 
response could experience a shift from the initial local response to a systemic one, a 
hyper-inflammatory response (Crespo et al. 2017). This hyper-inflammatory response is 
the combination of the inflammatory reaction to a persistent insult, the environment, and 
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even the pathogens’ own reactions to its host, creating a hyper-inflammatory phenotype 
(HIP), especially within chronic situations (Crespo et al. 2017). However, due to the 
specificity of the individual response, not all individuals will experience a shift to a HIP 
when encountering a pathogen. 
Understanding why this shift to a HIP happens, how it is maintained and the 
health consequences of such, all within the biosocial context of the individual are 
compelling reasons for further investigation. Like the individual, the immune system and 
its inflammatory response do not exist in a vacuum, and neither should the multiple 
disciplines that consider health, especially any investigation of health in the past 
(Reitsema and McIlvaine 2014). The challenge then becomes, how would it be possible 
to study this phenomenon in past populations, and what sort of information could it 
provide? With the obvious ethical and logistical problems of studying these questions in 
living populations, evidence about both contemporary and past populations must be 
derived from other sources. While the work of many biological anthropologists utilize 
modern populations and synthesize human biology with anthropological frameworks, 
even here there are limitations, including how much can be extrapolated to the past. One 
of the draws of bioarchaeology is its interdisciplinary nature, and it is this dynamic 
approach to analyses that even allows for collaborative work, such as proposed here with 
connections made between immunological and bioarchaeological perspectives, with 
potential for understanding immune competence in the past (Crespo et al. 2017; Larsen 
2015; Larsen 2018). Indeed, a multidisciplinary approach allows for different 
methodologies and perspectives to be taken together and is therefore necessary to begin 
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to reconstruct understandings of health, disease, and stress in past populations (Klaus 
2014; Reitsema and McIlvaine 2014).   
The IP in the skeletal record: Are reconstructions possible? 
The inflammatory phenotype provides valuable information that can help to better 
contextualize analyses of health and responses to stress. The problem becomes then, is it 
even possible to reconstruct an individual’s inflammatory phenotype? If so, it must be 
based upon osteological evidence, given the importance of the skeletal system for 
immune function and the interplay between these systems in life. This undertaking, to 
even start to reconstruct something as complex and varied as immune competence and an 
inflammatory phenotype from a skeleton, cannot be pursued via a single lens. Rather 
multiple perspectives must be engaged to help create a more nuanced perspective of what 
is observed in the bioarchaeological record. 
Here, the capacity of the field of 
bioarchaeology as a whole to embrace other 
disciplines, to integrate, contextualize, and 
synthesize data from outside the discipline, is 
crucial for a more holistic end assessment 
(Klaus 2014; Reitsema and McIlvaine 2014; 
Temple and Goodman 2014).  
The multidisciplinary approach (model) 
There are four prominent fields of 
study that lend themselves well to this task of 
reconstruction of an inflammatory phenotype: Figure 1 The Multidisciplinary Model  
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experimental immunology, osteoimmunology, archaeoproteomic analysis, and 
paleopathology. These fields were brought together in a recently proposed framework 
which established a trajectory for how to pursue this type of analysis (Figure 1) (Crespo 
2018).   
Experimental immunology  
 Experiments performed in vitro consider the mechanisms of inflammation itself, 
the cellular and chemical mediators of the inflammatory response. Teasing apart how 
specific inflammatory factors respond to insults via in vitro models may provide insights, 
i.e., how activated immune cells can affect inflammatory responses to a variety of 
secondary insults, which may then be extrapolated to other levels of analysis. 
In the context of chronic infections, and the inflammatory response on bone in 
that environment, experimental immunology provides tools to investigate a potential 
inflammatory shift at the level of the immune cells themselves (Crespo et al. 2017). 
Observation of lesions on the bone provides a wealth of information. Yet lesions and 
abnormalities may be nonspecific, and without context the true etiology of those 
abnormalities may not be known. Understanding the cellular players behind what is 
observed on bone, especially in the context of the HIP and chronic systemic 
inflammation, may not provide specific context to an individual, but it does provide 
another perspective of how what is observed came to be. Incorporating what information 
immunology and inflammation provide may help to elucidate more clearly what is left 
behind in the osteological record.  
This study into the dynamic interactions between the immune system and the rest 
of the body, and the immune system in response to actual or perceived threats, justify the 
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foundations of this model upon experimental immunology. These interactions between 
host and pathogen, and of the host with itself, create these sustained inflammatory 
environments in which change may happen to the bones, and teasing out the 
inflammatory pathways provides a starting point to work up from.  
Osteoimmunology 
 The logical follow up to and extension of experimental immunology lies in the 
emerging discipline of osteoimmunology. Osteoimmunology investigates how the 
immune and skeletal systems interact (Caetano-Lopes et al. 2009). Experimental 
osteoimmunology performed in vitro provides opportunity to investigate the underlying 
relationship between the bone at its fundamental cellular level and the immune system, 
i.e., how activated immune cells can affect bone cell differentiation and physiology, and 
how the cellular players from both systems interact and influence one another 
(Nakashima and Takayanagi 2009). While experimental immunology looks at how the 
immune system interacts with itself, and with outside players (pathogens), 
osteoimmunology examines the more specific relationship of how the immune system 
interacts with bone. Both perspectives are necessary, and to understand lesion formation 
bone physiology and biology within the context of immune interaction must be 
considered.  
 There is plenty of overlap within these two experimental fields. Osteoclasts and 
immune cells share many of the same regulatory molecules, such as cytokines. The 
cytokines that are implemented in proinflammatory activity in turn exert influence on  
bone cells as well (Nakashima and Takayanagi 2009). It stands to reason that in chronic 
inflammatory environments there will be unintended consequences for bone at the very 
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least because these molecules can influence multiple types of cells (Caetano-Lopes et al. 
2009). There are already many cases of  bone damage and loss associated with 
inflammatory disorders (Takayanagi 2005). In addition, overlap with endocrine and 
homeostatic mechanisms provides another pathway leading to potential bone damage 
outside of traditional pathogens, especially since many of the molecular players in energy 
storage and retrieval (including vitamin D, osteocalcin, and cortisol) exert influence on 
osteoblasts and osteoclasts (Caetano-Lopes et al. 2009). Osteoimmunology provides a 
framework to start to investigate how interactions between the inflammatory response 
and bone cell physiology may be translated into the lesions or abnormalities observed in 
the osteological record. 
Archaeoproteomic analysis 
 The structure of bone is one of the most important aspects of the tissue, and the 
proteins that comprise bone are just as important for analysis as the cells and mediators 
that interact in the living system. Archaeoproteomic analysis provides the potential for 
the inquiry of bone at the level of its proteins. As bone is a dynamic living tissue, not all 
of its protein composition will be structural. After death, the chemical analysis of bone 
provides a wealth of information. Isotopic analysis provides insight into diet, with the 
potential for behavioral and ecological inferences from such, laying a groundwork for 
this type of analysis (Larsen 2015).  
 One of the major setbacks to chemical analysis has been the changes that bone 
undergoes postmortem. Bone is comprised mainly of type I collagen, and non-
collagenous proteins are only a small fraction of bone proteins, yet these non-collagenous 
proteins are the ones of interest. After burial, these organic proteins undergo deterioration 
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and other chemical changes, making the analysis of ancient bone problematic. However, 
recent work on refined protocols and analyses are bringing the potential of 
archaeoproteomic analysis on bones forward (Cersoy et al. 2019; Sawafuji et al. 2017). 
Indeed, a recent study was able to use protein analysis to identify the presence of 
pathology biomarkers in the bone (Pérez-Martínez et al. 2016).  
 The great potential of this emerging field is detecting proteins that can be 
indicative of the processes that occurred in life. Analyzing protein from a miniscule 
sample of powdered bone could potentially capture the presence of inflammatory (or 
other stress) markers in the bone postmortem, something previously undetectable. The 
presence of these proteins may be more indicative of the inflammatory processes that 
occurred in life, providing a more nuanced understanding of that individual’s health, 
regardless of whether there was observable lesion formation. A potential correlation in 
detectable immune proteins (or signals thereof) and lesions provides another new avenue 
to expand understandings of health from the bioarchaeological record. This type of 
proteomic analysis may potentially provide a much more powerful understanding of 
health in life than previously possible from skeletonized remains alone (Sawafuji et al. 
2017). For example, detection of osteocalcin (important in life in part for its role in 
energy regulation) from bone not only sets up the potential for further analysis of health 
and stress during life from bone, but the potential to identify stress in an individual before 
any physical lesions had a chance to manifest (Scott et al. 2016).  
Paleopathology 
No analysis of health, stress, or disease in the past is possible without utilizing the 
basics of paleopathological research. Paleopathology relies on both the biological and 
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social sciences to describe and classify the diversity of abnormalities of the human 
skeleton (Ortner 2011). Yet this discipline is more than just route classification. 
Paleopathology at its core is an interdisciplinary pursuit, utilizing methodologies and 
ideas from other disciplines to substantiate its own foundations. It is a complementary 
field to bioarchaeology, drawing on much of the context that bioarchaeology provides, 
and vice versa. Fundamentally, paleopathology is rooted in the anatomical analysis of 
bone abnormalities, but collaborative work with a variety of other disciplines allows 
expansion of the application of paleopathology to multiple questions, not least of which is 
the role of disease in human societies and reconstructions of pathogen-human interactions 
(Ortner 2011).  
  The analysis of observable lesions and abnormalities is the final piece of this 
model to begin to reconstruct the inflammatory phenotype. All of these fields provide 
valuable information about some specifics of health, but paleopathology grounds these 
disciplines in the observable anatomical record. Archaeoproteomics may analyze the 
proteins from bone, but paleopathology sets the foundation for observing and classifying 
the abnormal. While cellular and molecular studies work out the myriad intricate 
pathways that eventually lead to lesions, paleopathology has the tools for the immediate 
observation. The actual study of bone, and the continued observations of such are 
necessary to ground and orientate the research questions and goals of the other fields. 
Paleopathology must be consulted as it provides this foundation for interpreting the 
diseased skeleton within the context of these other analyses.  
That is not to argue that any one field is of more importance than another within 
this model. Rather, this model provides a starting point to frame questions about the 
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potential of reconstructing past inflammatory processes, with each part contributing a 
piece to the puzzle. These four disciplines each provide unique perspectives that work 
well in concert with one another, building off of, and expanding the analysis. It is not 
possible to immediately compare or extrapolate the results of an in vitro experiment to an 
observable lesion in bone. However, by taking the information from experimental 
immunology and expanding that to questions of osteoimmunology, it is possible to start 
to build a context in which questions of inflammation are relevant. Archaeoproteomics 
moves that context of inflammation and bone from in vitro, to proteins sampled directly 
from bone. Paleopathology provides the examples of what the osteological record can 
provide, that may help to orientate and contextualize what the other three fields have built 
up to. Inflammation cannot be understood in the context of the skeleton without 
understanding the mechanisms that occur in life. This model provides a starting point, 
building off of each disciplines’ relevant contributions to start to piece together a more 
nuanced picture of the whole: a reconstruction and understanding of the inflammatory 
phenotype from the bioarchaeological record.  
The IP in skeletal samples: Searching for experimental evidence  
It is not enough to make inferences about inflammatory processes based solely on 
osteological observations. If it is possible to reconstruct an inflammatory phenotype using 
the above model, then the start of any such analysis must be grounded in the experimental 
component. Understanding inflammation and inflammatory environments is the 
necessary first step to provide the context to test subsequent hypotheses. The how and the 
why of inflammation provide the background to better understand events that may push 
an individual into a HIP. Findings from the experimental component are necessary for 
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further considerations of how inflammation, and the HIP, may affect subsequent 
pathological developments, and what may be observed in the osteological record. The 
starting point for reconstructing an inflammatory phenotype must be with experimental 
immunology, to provide the basis for understanding the how and the why of the 
inflammatory process. These in vitro models provide a chance to start to look at the 
underlying roles of, or at least some specific responses of, inflammatory mediators not 
possible with the other disciplines of this model. Questions that aim to tease out the 
basics of immune and altered immune responses start to lay this groundwork.  
Would the shift into a HIP be an isolated occurrence, or could typical host-
pathogen interactions spur a HIP within the right context? In consideration of the HIP, it 
becomes prudent to consider a situation in which a familiar pathogen that elicits a known 
inflammatory response, may end up in turn modifying subsequent inflammatory 
responses, albeit indirectly. Based on how interconnected the immune system is this 
makes sense, and this indirect modification of subsequent responses is of particular 
interest, as this may play into the shift to a HIP. For example, does an infection with 
Mycobacterium tuberculosis indirectly modify the host’s subsequent response to later 
secondary infections, such as those produced by Porphyromonas gingivalis or 
Staphylococcus aureus (pathogens commonly associated with nonspecific osteological 
lesions)? That is, does the initial insult (tuberculosis) influence the host’s inflammatory 
response to the second insult (staph infection), eliciting an inappropriate response to that 
second insult, which would not have occurred without the initial insult? Is this enough to 
potentially push the individual into a HIP? An in vitro model that compares basic 
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immune cell reactions to one or more threats provides some insight into whether 
subsequent insults 
would be enough to 
shift the inflammatory 
response (Figure 2).  
 The immune 
response is more 
intricate than just a 
series of set responses. 
Pathways other than 
direct pathogen 
interaction may modulate the inflammatory response. Cytokines are a basic part of the 
proinflammatory response, and while generally produced by cells at the site of infection, 
they also play a part in systemic inflammation. Exposure to proinflammatory cytokines 
can act as primers of immune cells. The next experimental question then becomes, do 
those immune cells exposed to other proinflammatory mediators subsequently adjust their 
own inflammatory response? Does, in a sense, priming these immune cells (via contact 
with proinflammatory mediators) influence their subsequent responses to other insults? 
An altered immune response based on subsequent exposures, or priming, may be part of 
the process that contributes to altered or inappropriate inflammatory responses.  
The questions raised by experimental immunology reflect back on the broader 
question of what are the potential consequences of the shift to a hyper-inflammatory 
phenotype? If it is possible to tease out some of the consequences of such a shift, could 
Figure 2 Shifting into a HIP 
How might the shift into a HIP occur? a.) The sequence of events in life that may promote 
a HIP, from an initial insult, followed up with a secondary exposure in the context of an 
activated immune response, and the potential end result of a sustained inappropriate immune 
response or HIP. While not directly comparable, b.) presents a basic in vitro model that 
attempts to follow the same trajectory, that compares basic immune cell reactions to initial 
and secondary exposure and measures the end response. Is this series enough to potentially 
push an individual into a HIP? 
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that be used in turn to better understand and reconstruct the inflammatory phenotype, or 
even immune competence in past populations via the osteological record? While reducing 
the inflammatory process to basic in vitro models leaves out the nuances and 
confounding factors of real life, it does allow for a starting place to understand the 
fundamental underlying mechanisms of inflammation, providing a clearer look at the 
potential ways that this process can be initiated. 
Utilizing this four-field framework, and the context and grounding that the 
experimental components add. as well as understanding the immunological shifts that 
create inflammatory environments, can help contextualize the end result of pathological 
processes. Adding in the context of the biosocial environment, reconstructions of the 
(hyper) inflammatory phenotype have the potential to provide a more nuanced look at 
health and disease in the past. Specifically, the great potential of the HIP placed within 
these contexts (immunological; inflammatory; osteological; biosocial) is its integration 
into analysis of skeletal lesions. The identification of lesions on the bone where 
inflammation and inflammatory processes were present, or likely present, adds more 
physical grounding to these questions investigating reconstructing the IP. The pursuit of 
experimental evidence at all levels lends itself to the creation of a ‘skeletal inflammatory 
index’ (SINDEX), a framework which further integrates the cellular and immunological 
processes in conjunction with mechanisms of lesion formation (Crespo 2018). This index 
could be used to better understand inflammation and the inherent issues of such, with 
what is observed in the osteological record. While the IP and immune competence vary 
from person to person, this index could help to contextualize individuals within a 
population and a specific environment. The use of this index, utilizing the 
34 
 
multidisciplinary model that provides the backbone for analysis, allows for the potential 
of creating more comprehensive bioarchaeological reconstructions of health, disease, and 
stress in these past populations, one piece of the puzzle at a time, all starting with an 








OBJECTIVE AND HYPOTHESIS 
 
Objective 
The general objective of this thesis is to provide experimental evidence to 
contribute to the multidisciplinary reconstruction of IP in skeletal samples (presented in 
Figure 1). 
The specific objective of this thesis is to determine if immune cells activated, or 
primed, in vitro, can generate an inflammatory shift altering their immune responses to 
pathogens (P. gingivalis and S. aureus) commonly associated with persistent infections 
(such as those associated with periodontal disease [PD] or periosteal lesions [PL]).   
Hypothesis 
We predict that after the first day, pre-stimulated cells (mimicking a 
hyperinflammatory phenotype) will show increased expression of pro-inflammatory 
cytokines when these same cells are exposed to oral pathogen P. gingivalis or periosteal 
associated pathogen S. aureus. After the second day, we predict that those cells exposed 
to P. gingivalis or S. aureus will also show higher expression of inflammatory cytokines 
(TNFα; IFNγ; IL-1β), when compared to corresponding controls (i.e., non-pre-stimulated 




 Repeated experiences of acute or chronic stress can induce chronic inflammation, 
and this can potentially lead to dysregulation of the systemic and local expression of 
inflammatory proteins, consequently impacting inflammatory processes against local 
pathogens; ultimately leading to a hyper-inflammatory phenotype (HIP) (Black 2003; 
Stelekati and Wherry 2012). To “mimic” an inflammatory shift (i.e., to generate cells 
with a “hyperinflammatory phenotype”), we propose to pre-expose human immune cells 
to inflammatory inducers such as: lipopolysaccharide (LPS), and pro-inflammatory 
cytokines interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα), and later 
expose those “pre-stimulated” cells to the pathogens often linked to the osteological 
markers commonly associated with inflammatory processes (Chen et al. 2015; Kraaij et 
al. 2014; Li and Lin 2008). Our predictions lend support to the preliminary hypothesis 
where preliminary exposure to inflammatory inducers will generate an inflammatory shift 
that will persist and impact a secondary infection by oral or periosteal pathogens. This 
line of evidence will help in the reconstruction of increased severity (inflammation) in 
PD and PL in individuals with systemic stress and potentially with systemic 
inflammation. Recently published evidence on how chronic infections (such as 
tuberculosis and leprosy) can impose an inflammatory shift on the immune response to 





MATERIALS AND METHODS  
 
Ethics approval 
 For the in vitro analysis peripheral blood mononuclear cells (PBMCs) from 
healthy voluntary donors were collected at the University of Louisville Nephrology 
Research Laboratory. The blood sample collection, including the corresponding subject 
informed consent document, was approved by the Institutional Review Board (IRB) of 
the University of Louisville; the assigned number is 191.96. The collection of PBMCs 
and experimental protocols for the current study was marked as Exempt within the same 
IRB (.96), under tracking number 11.0334. 
Cell culture 
The PBMCs were collected and subsequently isolated from venous blood at the 
University of Louisville Nephrology Research Laboratory by dextran sedimentation and 
density centrifugation in a Percoll gradient as described previously (Haslett et al. 1985). 
PBMCs were then transported on ice to the laboratory where the experiments were 
carried out in full. The cells were centrifuged for 10 minutes at 1500rpm at 4 degrees 
Celsius. The original media was removed, and the pellet was resuspended in 40ml of PBS 
(Phosphate buffered saline, ph7.4 (Gibco Life technologies, ref#10010-02)) in order to 
wash the PBMCs. A sample (125µL) of the resuspended cells was taken and placed into a 
2ml tube on ice. An additional 125µL of Trypan blue stain (Gibco Life Technologies .4%
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lot #1311086) was added to stain the cells. 10µL were taken from this sample and 
counted on a hemocytometer. Using a standard microscope, cells were counted according 
to what fell in the hemocytometers grid. An average of cells per grid was taken. The cell 
count was determined using the following formula: N = cell count in grid x 10,000 x 
2(dilution factor). The final cell count is N x the final volume (40ml). After counting, 
the cells were centrifuged again at the same conditions. The PBMCs were then re-
suspended in complete medium RPMI 1640 containing 10% FCS, penicillin (100 U/ml), 
streptomycin (100 g/ml), sodium pyruvate (1 Mm), and nonessential amino acids (0.1 
Mm).  
These protocols are based on a cell density of 4 x 106 in 1ml of media per well. 
The volume of media required for resuspension to achieve the final cell density per well, 
was determined by the number of PBMCs available from the donor on that day. The total 
number of available PBMCs varied with each donor, but all wells and conditions had the 
same cell density per well. Immediately after resuspension in the appropriate volume of 
media, the cells were seeded into 24 well plastic cell culture plates at a density of 4 x 106 
in 1ml of media per well and subsequently followed the corresponding experimental 
protocols. This collection protocol has been successfully utilized in this laboratory 
previously (Crespo et al. 2017).  
Reagents for experimental protocols  
 
PBMCs were pre-stimulated/primed in vitro with lipopolysaccharide (LPS) (from 
E. coli 0111: B4; a general proxy for bacterial infection) (Sigma, St. Louis, MO) at a 
working concentration of 10µL per the final volume of 1ml for each well. LPS was used 
to act as a general T-cell receptor stimulus agonist to induce an inflammatory response 
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and used primarily as a positive control. Recombinant TNFα and recombinant IFNγ 
(Affymetrix-eBioscience, San Diego, CA) were used for the priming of PBMCs, as well as 
to induce a hyperinflammatory response. TNFα was used at a working concentration 
10µl/well, and IFNγ was used at a working concentration of 5.25µl/well. For mimicking 
the bacterial infection several different whole sonicated bacterial lysates were used. 
Mycobacterium tuberculosis (Seeley et al. 2008) (BEIResources, NR-14822) was added 
at a working concentration of 1µL/well. Mycobacterium leprae (LP) (BEIResources, NR-
19329) was added at a working concentration of 10µL/well. Porphyromonas gingivalis 
(Pg) (obtained from Dr. Richard Lamont’s lab at the Department. of Oral Immunology 
and Infectious Diseases; University of Louisville) was used at a working concentration of 
100µL/well. Finally, Staphylococcus aureus (Sa) (Pansorbin cells-Calbiochem # 507861, 
EMD Millipore, Billerica, MA), was used at a working concentration of 4.4µL/well. S. 
aureus was heat killed and formalin fixed unlike the other three whole sonicated lysates.   
Experimental protocols  
 
A 48-hour experiment was set up (Figure 3) to investigate how pre-
stimulated/primed 
PBMCs in vitro can 
generate an 
inflammatory shift, 
that is, alter their 
inflammatory response 
to sequential exposure 
to pathogens. After re- The multiday in vitro experimental model to investigate PBMCs response to stimuli, that is, 
how the inflammatory response may be altered. 
Figure 3 The General Experimental Model  
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suspension and seeding onto a 24 well plate, PBMCs were exposed to either LPS, TNFα, 
or IFNγ (as well as bacterial lysates). The cells were left for a period of 24 hours, 
constituting the first day. On the second day, the PBMCs were collected, and pipetted 
into 1.5ml tubes. The cells were then centrifuged at room temperature for 2 minutes at 
6000rpm. The supernatants were collected and aliquoted into 300µl portions and stored at 
-20 degrees Celsius. The cells were then re-suspended in 1ml of fresh RPMI and reseeded 
onto the plate, in previously unused wells. The cells were then exposed to bacterial 
lysates or other controls and left for an additional 24-hour period (constituting day 2). 
This process was repeated at the end of day 3 (the end of the 48-hour period), with 300µl 
aliquots of supernatant placed into storage at -20 degrees Celsius.  
The aliquots of the supernatants were used primarily for cytokine analysis of 
TNFα; IFNγ; or IL-1β by an enzyme-linked immunosorbent assay (ELISA) (Affymetrix-
eBioscience, San Diego, CA). Extensive controls were used on both days of the 
experimental protocol (see appendix 1 for example of an in-lab experimental protocol 
form). To avoid disruption in cytokine expression, the experimental protocols were not 
run longer than a total of 48 hours. While experimental time length varies depending on 
the clinical or research question, this time window (48 hours) was the most conservative 
and allowed for the comparison of the results with most cytokine in vitro profiles in 
healthy donors (for a comprehensive review see (Warle et al. 2003)). Three variations on 
this basic experiment were run. 
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Protocol 1: Pre-activation with bacterial lysates and sequential immune responses to S. 
aureus and P. gingivalis 




leprae (LP) lysates 




to persistent, or 
local, pathogens, either S. aureus or P. gingivalis. That is, does a higher expression of 
inflammatory cytokines (in circulation due to pathogen exposure) generate a systemic 
shift, and if so, does this systemic hyperinflammation in turn affect inflammatory 
responses against other persistent infections, such as the one often present in periosteal 
lesions (commonly associated with S. aureus) or periodontal disease (commonly 
associated with P. gingivalis)? To measure whether cytokine expression changed with 
early exposure to TB or LP lysates in vitro human PBMCs were exposed to Sa, TB, or LP 
lysates on day 1, and subsequently on day 2, cells were collected, washed, and 
resuspended in fresh medium, and exposed for another 24-hour duration to the same, or a 
different pathogenic insult (Figure 4). All supernatants were collected on day 2 and day 3.  
Figure 4 Protocol 1: Pre-activation with bacterial lysates  
In this protocol, naïve PBMCs from healthy donors were first exposed to bacterial lysates, and then 
sequentially exposed to a second bacterial lysate, either Pg or Sa. The initial exposure to TB or LP 
mimicked a systemic HIP, and the subsequent responses to further pathogen exposure were measured.  
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 Protocol 1 contributes to the objective of the thesis by exploring what might 
generate an inflammatory shift, altering subsequent immune responses to pathogens that 
are commonly connected with persistent infections associated with periosteal lesions and 
periodontal disease, observable in the osteological record. That is, can other infections be 
a driving factor in generating a systemic inflammatory shift? 
Protocol 2: Pre-activation with proinflammatory mediators and sequential immune 
responses to S. aureus and P. gingivalis  
 The objective of this protocol was to determine if pre-stimulated PBMCs would 
shift the inflammatory response when those same cells were exposed to subsequent 




or IFNγ, to 
prime the cells, 
but not bacterial 
lysates. After 24 
hours, the cells 
were collected, 
washed, and resuspended in fresh medium (same as previous protocols) and then exposed 
to either Pg or Sa. Supernatants were collected at the end of day 2 and day 3. This 
approach allowed for investigation of whether the pre-stimulation of naïve PBMCs 
(mimicking the hyperinflammatory phenotype) could induce an immunological shift, that 
Figure 5 Protocol 2: Pre-activation with proinflammatory mediators 
In this protocol, naïve PBMCs were primed via exposure to a proinflammatory mediator (cytokine or LPS), 
and then sequentially exposed to a bacterial lysate, either Pg or Sa. The priming of the PBMCs was in order to 




is, change the inflammatory response with sequential exposure to oral or periosteal 
pathogens (P. gingivalis or S. aureus). Those pathogens are commonly associated with 
persistent infections (such as those associated with periodontal disease [PD] or periosteal 
lesions [PL]), and often linked to the osteological markers commonly associated with 
inflammatory processes.  
 Protocol 2 directly reflects the specific objective of this thesis: to determine if 
immune cells activated/primed in vitro, can generate an inflammatory shift altering their 
immune responses to pathogens (P. gingivalis and S. aureus) commonly associated with 
persistent infections and osteological markers associated with inflammation, even if the 
stimulating factor was not direct exposure to a pathogen. 
Protocol 3: Indirect immune responses 
 
The objective of this protocol was to investigate if immune factors released by 




expression by naïve 
PBMCs, or PBMCs 
previously exposed to 
S. aureus. In this 
approach, (Figure 6) 
supernatant from 
PBMCs that had been 
In this protocol, the supernatant of previously exposed PBMCs was used to determine if an 
indirect immune response might elicit an inflammatory response, for either naïve cells, or 
PBMCs previously exposed to Sa. Only the products from PBMCs previously exposed were used 
in the sequential exposure, no new lysates or proinflammatory mediators were used to elicit a 
response.  
Figure 6 Protocol 3: Indirect Immune Responses  
44 
 
exposed to TB or LP and collected on day 1 was subsequently used on naïve PBMCs (or 
primed by Sa) for the day 2 exposure. All supernatants were collected on day 2 and day 
3, following the same procedure in protocol 1. This allowed for an investigation of 
whether there would be a subsequent shift in the expression of immune proteins, as well 
as tested whether immune factors (cytokines TNFα; IFNγ) released by activated PBMCs 
could affect the cytokine expression of PBMCs (naïve or exposed to Sa) mimicking a 
systemic impact on distant tissues.  
 Protocol 3 contributes to the objective of the thesis by investigating one route that 
immune cells may become activated/primed, even indirectly via exposure to other 
circulating cytokines and not through direct pathogen contact. Indirect stimulation of the 
immune system can have systemic consequences, of importance to inflammatory 
processes associated with osteological lesion formation. Protocol 1 measures cytokine 
expression from PBMCs directly exposed to lysates, while this protocol measures 
cytokine expression from naïve cells with indirect exposure. 
Cytokine assays  
 
Cytokine expression (TNFα; IFNγ; IL-1β) was determined by an enzyme linked 
immunosorbent assay-ELISA (Affymetrix-eBioscience, San Diego, CA). This technique 
allows for the quantitation of soluble proteins in the samples; that is, which immune 
proteins were present in the collected supernatants from the experiments. The established 
protocol outlined by the manufacturer of the assay kits was followed, a brief summary 
follows: the provided 96 well plates were coated (diluted coating buffer and deionized 
water) and plated with the capture antibody. The plate was left at 4 degrees Celsius 
overnight. On the second day, the plate was washed three times with washing buffer 
45 
 
(450µl deionized water, 50µl PBS, and 250µl Tween (Sigma Life Sciences, #P2287)). 
The supernatants to be used were thawed on ice, while the plate was blocked with diluent 
for an hour. 200µl of each supernatant was pipetted into the appropriate wells, and a set 
of standards was also added (see appendix 2 for an example of an ELISA plate layout; 
one was filled out for each plate run). The plate was left overnight at 4 degrees Celsius. 
On the third day the plate was washed thoroughly with washing buffer, the detection 
antibody was added and left at room temperature for one hour. After another round of 
washing, the enzyme was added. After 30 minutes the substrate was added. At this point 
the color of the plate changed from clear to blue if the plate had been set up correctly, 
visible at least in the 6-8 standards and controls added to every plate. After 10 minutes a 
stop solution was added (H2SO4 and deionized water). The color changed from blue to 
yellow and the plate was read on a microplate reader (Biorad, iMark reader). 
Concentrations were calculated by comparison with recombinant cytokine standards. 
Within each sample (healthy donor) all experimental conditions were run by duplicate, 
and the results were compared to stimulus-free controls and standard positive controls.  
Statistical analysis 
 
 The statistical analyses were run on data collected over the course of several 
years. Data collected specifically for this thesis is based on 26 individual healthy donors. 
Previous relevant data and conditions from the laboratory consisting of an additional 27 
healthy individual donors are included where relevant to help substantiate experimental 
conditions. As previously conducted for similar experimental protocols, within each 
sample (one healthy donor) all experimental conditions were run by duplicate, and the 
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results were compared to both stimulus-free controls (untreated conditions) and positive 
controls (Crespo et al. 2017). 
 Some conditions expressed low enough cytokine expression that it was below the 
limit of detection of the plate reader and is represented by a (-) sign in the raw data. 
While the exact value is unknown, for purposes of statistical analysis all zero values are 
replaced with .005, the plate readers mechanical limit of detection. Using the limit of 
detection as a place holder allows for analysis without assuming that those values are a 
true zero. Some conditions expressed a high enough cytokine reading that it was also 
beyond the limits of the plate reader. The plate readers photometric optical density limit 
is 3.5. Values higher are represented by a (+) sign in the raw data. For the purposes of 
statistical analysis, all of these values were interpolated based on a line of best fit (y=mx 
+ b), based on the particular slope and intercept for the specific plate that the high 
readings were run on.  
 For the statistical analysis outliers were identified and removed. While outliers 
from biological data do not necessarily represent mistakes or errors, they were removed 
here for the purposes of subsequent between group comparisons (Motulsky 2014). 
Including outliers allows for the possibility that the interpretations will be skewed. To 
balance between removing outliers, but not removing important data, a conservative 
approach was taken for identification of outliers. Outliers were determined as falling 
outside a range of three times the standard deviation plus the mean, or the mean minus 
three times the standard deviation. Using three times the standard deviation (as opposed 
to two times or less) helps to reduce the absolute size of bias, as by extending the range 
fewer observations are removed (Miller 1991). The extended range captures as much of 
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the inherent variation as possible, but also removes extraneous values well beyond the 
distribution of the group. Every condition was placed into a scatterplot to visually check 
the distribution for outliers as well.  
Outliers were removed from conditions as opposed to from donors. Every 
experimental condition was tested for outliers, for example the condition LP/LP for 
TNFα with a sample size of 38, had one outlier. Each condition has a different sample 
size, as not all conditions were run for every donor. Individual donors are not compared 
to one another, rather it is the group of donors as a whole that contributes to each 
condition, and these groupings are compared to one another. This more conservative 
approach to outliers allows each condition regardless of sample size to keep as many 
donors as possible to preserve inherent variability, but also removes data that is likely to 
skew the end results. Removing an entire donor could impact the distribution of all other 
conditions run with that donor. However, if a donor presents with multiple outliers over 
the experimental conditions in which they were run, then by removing those from each 
experimental condition where they present amounts to the same as removing the entire 
donor.  
 The interpolation of values and the removal of outliers prepared the data for 
analysis. The initial statistical analysis was run on GraphPad Prism. Before comparing 
any of the groups, F-tests were run, which tested the hypothesis that two groups being 
compared will have identical standard deviations and thus equal variances (Motulsky 
2014). The F-test was used as a test against the normality assumption, that is, the 
distribution of each group is identical. Distribution matters, as comparing groups 
48 
 
assumed to be in Gaussian distribution with groups that are not would not produce valid 
results; Gaussian distribution was not assumed. 
 The F-test determined distribution of the group, indicating whether a parametric 
test or nonparametric test was relevant. Based on the results of the F-test, which indicated 
that the groups were not equal in variance, a nonparametric test was chosen: the Kruskal-
Wallis one-way ANOVA. This compared the means of three or more groups (Motulsky 
2014). The “one-way ANOVA computes a single P value that tests the null hypothesis 
that all groups were sampled from populations with identical means” (Motulsky 2014). 
Groups were limited to four to five conditions, generally the 24-hour condition and 
subsequent 48-hour exposures. The one-way ANOVA indicated whether within this 
group if there was any significant difference between the means compared. However, this 
does not indicate which conditions are different from one another within the group. To 
determine which conditions are significant from the Kruskal-Wallis test, a post hoc 
nonparametric test is required. 
 Dunn’s multiple comparison is a post hoc nonparametric test, which tests the 
difference between groups, and tends to produce very conservative results (Motulsky 
2014). For our purposes, the groups Dunn’s multiple comparison test is testing are the 
individual conditions within the subset group the one-way ANOVA was run on. Most 
importantly, groups can be unequal in size, as this is a nonparametric test. From this, an 
adjusted P value of less than .05 was used to determine significance, with an adjusted P 
value of less than .1 to be considered a trending value and notable for discussion. 
For the case of the cytokine IL-1β, where limited samples were available, the 
number of comparisons of groups available was often only two at a time, less than the 
49 
 
required number for the previous tests. A one-way ANOVA was run for all of the IL-1β 
experimental conditions and groups when available, such as broad comparisons of Pg or 
Sa. For further comparisons, the Mann-Whitney test was used. This nonparametric test is 
used to compared two unpaired groups to compute the P value, that in larger groups the 
Dunn’s multiple comparisons was used for (Motulsky 2014). 
While nonparametric tests do not have the same power as parametric tests, for the 
purposes here nonparametric tests best fit the data. The nonparametric tests which focus 
on the median, are a better description of this data. Even with the removal of outliers, 
high data points within a group can skew the mean. The nonparametric tests observe the 
ranking of the data instead, and while these tests tend to be quite conservative, these are 





The specific objective of this thesis is to determine if immune cells activated/ 
primed in vitro, can generate an inflammatory shift altering their immune responses to 
pathogens (P. gingivalis and S. aureus) commonly associated with persistent infections 
(such as those associated with periodontal disease [PD] or periosteal lesions [PL]).  
Protocol 1 Pre-activation with bacterial lysates 
 
The objective of this protocol was to determine if in vitro exposure of PBMCs to 
Mycobacterium tuberculosis or Mycobacterium leprae lysates (mimicking a HIP) 
impacted subsequent immune responses to persistent/local pathogen S. aureus commonly 
associated with periosteal lesion formation (Figure 7).  
Of particular 
interest in these 
experiments are the 
comparisons of 
conditions that are 
followed up by 
exposure to Sa.   
Overall, exposure to 
Sa appears to elicit 
a response as 
measured by 
Figure 7 IFNγ and TNFα expression from PBMCs exposed to bacterial lysates TB, LP, or Sa, 
followed with sequential exposure to TB, LP, or Sa.  
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cytokine expression of both TNFα and IFNγ. TNFα expression for conditions TB/TB 
compared to TB/Sa is trending with an adjusted P value of .0654, showing an increase in 
TNFα for TB/Sa. Initial exposure to LP also appears to promote an increase in TNFα, 
with comparison of TNFα expression for LP/LP to LP/Sa, with a significant adjusted P 
value of .0009, where expression is increased with exposure to Sa. Even with the same 
background (early exposure to LP), follow up with Sa produced a statistically significant 
increase in TNFα expression. The initial response to Sa, and subsequent exposure to Sa 
produces a uniform response for TNFα expression. Variations on TNFα expression are 
most apparent with initial exposure to either TB or LP.   
IFNγ expression is in general higher than TNFα. Similar significant differences 
are observed with an initial exposure to TB followed by a second exposure. IFNγ 
expression for TB/TB as compared to TB/Sa is significant with an adjusted P value of 
.0135, and TB/LP as compared to TB/Sa, is significant with an adjusted P value of .0007. 
In both cases, subsequent exposure to Sa increases cytokine expression. In addition, 
LP/LP as compared to LP/Sa is also significant, with an adjusted P value of .0003. Even 
in comparing UNT/LP to UNT/Sa, there is a difference in how these cells respond to the 
different lysates, with Sa inducing greater cytokine expression, with a trending adjusted P 
value of .0521 (see appendix for expanded results and adjusted P values).  
 This question can also be extended to Porphyromonas gingivalis: does in vitro 
exposure of PBMCs to TB or LP lysates (mimicking a HIP) impacted subsequent 
immune responses to persistent/local pathogen Pg commonly associated with periodontal 
lesion formation (Figure 8)? Initial exposure to LP appears to promote an increase in 
TNFα expression, as observed in comparison of LP/LP to LP/Pg, with a significant 
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adjusted P value of .0167. For exposure to TB, a comparison of TB/Pg to Pg/Pg TNFα 











following exposure to Sa and subsequent lysates, here exposure to Pg and subsequent 
exposures generally decreased both TNFα and IFNγ expression (see appendix for 
expanded results and adjusted P values for Pg).  
Protocol 2 Pre-activation with proinflammatory mediators  
 
The objective of this protocol was to determine if pre-stimulated or primed 
PBMCs can generate an inflammatory shift altering their immune responses to pathogens 
commonly associated with persistent infections. Here, PBMCs were primed with 
proinflammatory cytokines and then exposed to either PG or Sa lysates (Figure 9; Figure 
10). As was expected, there were significant differences in cytokine expression between 
the untreated controls followed up with exposure to one of the bacterial lysates (see 
appendix for full results and adjusted P values). 
Figure 8 IFNγ and TNFα expression from PBMCs exposed to bacterial lysates TB, LP, or Pg, 
followed with sequential exposure to TB, LP, or Pg 
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Changes in TNFα expression were of particular interest with secondary exposure 
to Pg. LPS/Pg as 
compared to IFNγ/Pg 
showed an increase in 
expression with an 
adjusted P value of 
.0163, an interesting 




TNFα expression was decreased as compared between TNFα/Pg compared to Pg/Pg with 
an adjusted P value of .0011, and between IFNγ/Pg compared to Pg/Pg, with an adjusted 
P value of <.0001. It appears here that early exposure to a proinflammatory cytokine 
elevated TNFα 
expression, as 
opposed to only 
exposure to the 
bacterial lysate, and 
for initial priming 
with IFNγ, significant 
increases in TNFα are 
observed following Figure 9 IFNγ and TNFα expression from PBMCs primed with proinflammatory 
mediators, followed with sequential exposure to Pg.   
Figure 10 IFNγ and TNFα expression from PBMCs primed with proinflammatory 
mediators, followed with sequential exposure to Sa.   
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with either Pg or Sa compared to UNT. Early priming with either TNFα or IFNγ 
produced significant increases in TNFα expression when followed by Pg as compared to 
Pg/Pg only. For early exposure to LPS, a component of gram-negative bacteria and used 
as a proxy for pre-existing bacterial infection, there was little difference in follow up 
exposures for TNFα expression. Early exposure to LPS did produce elevated TNFα 
expression, but less so as when compared to the same conditions for IFNγ (LPS/Pg 
compared to IFNγ/Pg, and LPS/Sa compared to IFNγ/Sa). While most comparisons 
regarding Sa were not significant, LPS/Sa as compared to IFNγ/Sa was borderline 
trending with an adjusted P value of .1242 for TNFα expression. While not significant, it 
is more interesting than the other conditions that generated adjusted P values of >.9999.  
IFNγ expression also displayed significant differences in the untreated controls 
with follow up exposure to a bacterial lysate (see appendix). IFNγ/Pg compared to Pg/Pg 
was statistically significant with an adjusted P value of .0268, with a decrease in IFNγ 
expression. LPS/Pg as compared to IFNγ/Pg was trending with an adjusted P value of 
.0991, with an increase of cytokine expression following priming by IFNγ, even though 
LPS is proinflammatory. IFNγ/Pg as compared to IFNγ/UNT presented a trending value 
for an increase in expression with an adjusted P value of .0531. Interestingly, LPS/Sa as 
compared to Sa/Sa, with a trending adjusted P value of .0875 and TNFα/Sa as compared 
to Sa/Sa, with a trending adjusted P value of .0875, displayed decreased cytokine 
expression as compared to just exposure to Sa, the opposite of what was observed with 
Pg and TNFα expression. LPS as compared to LPS/LPS actually exhibited a decrease in 
IFNγ expression, and LPS in general did not elicit a strong response regardless of follow 
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up. Interestingly there were not significant differences observed with initial exposure to 
IFNγ for IFNγ expression, unlike the dramatic changes observed with TNFα.  
Due to the limits of how many analyses could be run on the supernatant from one 
well (condition) (each ELISA used 200µl of supernatant) limited conditions were run for 








(Figure 11). Of 
interest for IL-
1β, were the 
proinflammatory mediators. A comparison of LPS/Sa to IFNγ/Sa was significant with an 
adjusted P value of .0112, with LPS/Sa exhibiting a higher IL-1β expression. The same 
comparison for TNFα expression was slightly trending with an adjusted P value of .1242, 
where IFNγ/Sa exhibited the higher expression. IFNγ/Sa as compared to IFNγ/Pg was 
significant with an adjusted P value of .0317, with IFNγ/Sa exhibiting a reduced IL-1β 
expression as compared to IFNγ/Pg. Sa/Sa as compared to LPS/Sa was not significant, 
but with a trending adjusted P value of .0986 is of interest, with LPS/Sa exhibiting a 
higher IL-1β expression. Interestingly, LPS/Sa as compared to Sa/Sa for IFNγ was 
Figure 11 IL-1β expression from PBMCs primed with proinflammatory mediators 
with subsequent exposure to either Pg or Sa. 
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trending with an adjusted P value of .0807, with Sa/Sa exhibiting a higher expression, the 
opposite of what was observed with IL-1β.  
For this protocol, a comparison of all cytokine expression was also made. 
Expanding the comparisons to the expression between the cytokines themselves for this 
protocol showed some significant differences in cytokine expression to different 
experimental conditions. Comparisons were also run between each of the three cytokines 
for the available conditions, results as follows. IL-1β expression was elevated 
significantly compared to IFNγ (adjusted P value .0042), but not TNFα for the LPS/Pg 
condition. IL-1β exhibited increased cytokine expression as compared to both TNFα 
(adjusted P value .0339) and IFNγ (adjusted P value .0009) for the LPS/Sa condition. 
Both IL-1β and TNFα were significantly elevated as compared to IFNγ (adjusted P value 
.0361 for IL-1β and .0046 for TNFα) for TNFα/Pg, but IL-1β and TNFα again showed no 
significant difference between the two. No significant difference for TNFα/Sa, but a 
trending difference between IFNγ and TNFα expression, with elevated TNFα expression. 
TNFα was elevated compared to IFNγ (adjusted P value .0225) for the condition 
IFNγ/Pg, but no difference was detected between TNFα and IL-1β expression. IL-1β was 
significantly reduced compared to TNFα for IFNγ/Sa (adjusted P value .022). For the 
Pg/Pg response, IL-1β expression was significantly elevated as compared to the IFNγ 
(adjusted P value .0002) and TNFα (adjusted P value .0037) response for Pg/Pg. There 
was no detectable difference in response to Sa/Sa. 
IL-1β expression in general was elevated as compared to the other two cytokine 
responses (see appendix). While no significant difference in response was observed in 
response to Sa/Sa between the cytokines, it is clear however, that there is immune cell 
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activation, as these PBMCs are still continuing to produce cytokines. Visually examining 
the experimental groups in addition to the 
statistical analysis provides additional 
information. Each dot on these column 
scatterplots (Figures 12,13) represents the 
cellular response for one individual donor. 
In certain instances, there is a clear 
division within the group of responders 
and non-responders. Responders are those 
PBMCs that exbibit cytokine production in response to the experimental conditions, 
regardless of whether it is significant or not. The non-responders are those PBMCs that 
exhibit little to no cytokine activity regardless of the exposure. Here it does appear that 
there is variation in how each sample is reacting within the different cytokine groupings, 
a difference that would be worth further consideration in future experiments, as IFNγ and 
TNFα show variation in responders while lL-1β does not (Figure 12).  
The same observation can be 
made for the TNFα/Sa condition as well, 
with no significant differences observed, 
but a trending difference noted between 
IFNγ and TNFα expression, with elevated 
TNFα expression. Here, there is notable 
distribution variation (Figure 13). 
Responders in the TNFα grouping are 
Figure 12 Variation in cytokine expression for Sa/Sa 
conditions.  
Figure 13 Variation in cytokine expression for the 




varied for both this condition as well as for Sa/Sa. This response may also suggest that 
those individuals whose cells are more likely to respond aggressively to stimuli, might 
also be those more likely to enter into a HIP.  
Protocol 3 Indirect immune responses 
 
The objective of this protocol was to investigate if immune factors released by 
PBMCs exposed to a pathogenic insult would affect subsequent cytokine expression by 
naïve PBMCs, or PBMCs previously exposed to Sa. For this particular protocol we chose 
to focus only on the stimulation of PBMCs that had been exposed to, or subsequently 
exposed to Sa, or Sa supernatant. Pg and Pg supernatant was not available for this round 
of experiments. One of the limitations of this experiment was that there were limited 
samples available, and the sample size for these experimental conditions tended to be 
smaller than the conditions for the other two protocols. Overall, previously unexposed 
PBMCs did exhibit activity based on exposure to supernatants alone on the second day 
Figure 14 IFNγ and TNFα expression from PBMCs sequentially exposed to supernatant from activated PBMCs 
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and cytokine expression does not appear to decrease with exposure to the supernatants 
(Figure 14).  
For TNFα expression, there was a significant difference between the UNT/UNT 
and the UNT/TBsp condition, with TBsp eliciting an increase in cytokine expression, 
with an adjusted P value of .0017. This elevated response for TNFα was also observed in 
comparison of TB/UNT to TB/TBsp with an adjusted P value of .0367. Here the early 
exposure to TB followed by exposure to the supernatant of PBMCs previously exposed to 
TB maintained an elevated cytokine response, one not observed when TB was followed 
up by the UNT condition. 
Early exposure to LP provided significant increases of TNFα expression followed 
up with Sasp as compared to LP/UNT (adjusted P value of .0299), or followed up with 
TBsp as compared to LP/UNT (adjusted P value of .0419), highlighting again the 
increase in cytokine production that would likely not occur without the supernatant 
stimulus. For IFNγ expression, a significant increase was observed in comparing the 
UNT condition with UNT/TBsp, with an adjusted P value of .008. IFNγ expression for 
UNT as compared to UNT/Lpsp, was trending with an adjusted P value of .0776 (see 
appendix for full additional adjusted P values). 
For early exposure to TB, LP, or Sa, there were no significant differences to 
report within or between any of the groups with subsequent exposures to supernatants. It 
is clear however, that there is immune cell activation, as these PBMCs are still continuing 
to produce cytokines. One of the limits of the tests used to determine significance here is 
that nonparametric tests tend to have less power with smaller sample sizes, and will not 
pick up on nuances in the data (Motulsky 2014). It would be inappropriate to use another 
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test for Protocol 2 data alone, and the distribution and methodology of this experiment 
indicate that this nonparametric test is still the best test for this data despite the small size 
limitation. Visually examining the experimental groups in addition to the statistical 
analysis provides additional information. By looking at the conditions grouped together 
by exposure in a column scatterplot, even with small samples sizes, this provides 
information about the distribution of the samples taken. 
In certain instances, there is a clear division within the group of responders and 
non-responders. Responders are those PBMCs that exbibit cytokine production in 
response to the experimental conditions, regardless of whether it is significant or not. The 
non-responders are those PBMCs that exhibit little to no cytokine activity regardless of 
the exposure. For example, in comparing conditions that are exposed to LP first and then 
followed up with supernatants, 
LP/TBsp is not significantly 
different from any other group 
except for the LP/UNT. The 
distribution of the samples shows 
that for LP/TB, half exhibit limited 
cytokine expression, but several 
others have elevated expression 
(Figure 15). Non-response may occur for a variety of reasons, and for future experiments 
an increased sample size would allow for the removal of non-responders (not just 
outliers). Analysis of only the responders to the experimental prompt may provide more 
information. The non-responders are not the same as an outlier, and do not meet the 
Figure 15 Variation in cytokine expression for PBMCs 
exposed to LP and sequentially exposed to various supernatants 
in protocol 3 
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Pre-activation with bacterial lysates 
The first experimental protocol investigated what might generate an inflammatory 
shift by determining if exposure to bacterial lysates would impact subsequent immune 
responses to another pathogen, in this case lysates of either S. aureus or P. gingivalis. TB 
and LP lysates served to create and mimic an environment in which there would be a 
higher expression of inflammatory cytokines already in circulation due to the previous 
exposure. In general, for both IFNγ and TNFα, the PBMCs exhibited increased cytokine 
expression between the untreated controls and subsequent exposures. This suggests that 
subsequent exposure to these lysates (Sa and Pg) elicits a greater cytokine response, 
which may be the type of response needed to push an individual into or maintain a HIP. 
That there are differences between the PBMCs’ response to different lysates with no prior 
experimental exposure (UNT), highlights an interesting response, and one that appears 
amplified with prior exposure to other lysates as observed in other conditions. These 
differences in subsequent exposure suggest that some immune alteration is occurring.  
Subtle variations in specific cytokine expression are both a reflection of 
individual variability as well as the physiological role of that cytokine. While the in vitro 
lab experiments do not capture the inherent complexity of these infections, some of the 
basic cytokine responses of such are still relevant. One of the limiting factors of these 
experimental models is the focus on a selected few cytokines, while in reality there are a 
multitude of cytokines that act in concert with one another and exert profound influences 
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on production and maintenance of cytokines, which in turn influences control of bacterial 
growth (Cooper et al. 2011). Cytokines play an array of roles depending on context, and 
for mycobacterial species they can act as both effectors and regulators of immunity 
against these species, as well as part of the innate immune defense against the initial 
infection (Cooper et al. 2011). IFNγ and TNFα have specific physiological roles, but act 
synergistically together in the context of mycobacterial infections (Lin and Flynn 2010). 
Together these proinflammatory cytokines activate microbial effector mechanisms in 
macrophages, and an observable increase in IFNγ often reflects an increased bacterial 
burden (Lin and Flynn 2010; Ottenhoff 2012). To aggravate matters there is evidence that 
mycobacterial infections delay the onset of acquired immunity, as opposed to the course 
of immune activation observed in other infections (Ottenhoff 2012). This helps to 
contextualize the increases in cytokine production observed in the in vitro plates, where 
the PBMCs are displaying increased production of these two cytokines that work in 
concert with one another.  
Cytokine expression however is a double-edged sword, with consequences 
following a shift too far in either direction. Repeated exposure of M. tuberculosis antigen 
in infected individuals can lead to the development of purulent inflammation, which is 
quite detrimental to the host (Cooper et al. 2011). Small shifts in cytokine expression 
clearly can have detrimental systemic impacts, and in regards to specific types of 
interferon production in specific contexts can promote, not hinder, bacterial growth 
(Cooper et al. 2011). Sensitization to cytokines and their effects must also be considered 
as well. In an animal model repeated injections of TNFα led to differing immune results 
dependent on dose and timing, but with the potential of decreased response to the 
64 
 
stimulating bacterium (Dantzer 2001). Even interactions of host receptors (in the case of 
mycobacterial species: TLR2) with LPS during the act of phagocytosis, can lead to the 
impediment of continued cytokine synthesis and decreased cytokine responsiveness 
(Huynh et al. 2011). Cross-sensitization between cytokines and nonimmune stressors has 
been reported, and further complicates the balance of cytokine production and 
effectiveness of immune response (Dantzer 2001). Perhaps such sensitization may 
explain the lack of significant increases in TNFα expression of the PBMCs exposed to 
TB, with subsequent exposure to the same or similar pathogen.  
This dynamic back and forth with the mycobacterial infections set up a busy 
environment in which unrelated additional pathogens enter into. Adding into this mix an 
infection with S. aureus is of interest, as this is a bacterium already renowned for immune 
system avoidance (Fedtke et al. 2004). S. aureus may be adept at perseverance in the 
host, but it does not completely avoid detection. Detection of S. aureus is enough to 
promote a systemic cytokine response, especially in regards to TNFα production 
(Fournier and Philpott 2005). However, in cases of gram-positive infections, such as S. 
aureus, the initial cytokine response is considerably delayed as compared to gram-
negative infections (Fournier and Philpott 2005). This delay is problematic, as the 
continued increase in cytokine production to deal with an evasive pathogen is also 
associated with the development of septic shock and multiorgan dysfunction (Fournier 
and Philpott 2005). In this context of an immune system fighting two different types of 
infection, the substantial increase in proinflammatory cytokine production would also be 
enough to spur the development of a cytokine storm, and the major proinflammatory 
cytokines (IFNγ and TNFα) considered in these infections are also major systemic 
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players in such storms (Tisoncik et al. 2012). All of this makes sense why increases in 
cytokine expression following subsequent exposure to Sa are observed in this protocol. It 
also suggests that this secondary unrelated infection would be enough to trigger immune 
alteration, abnormal cytokine cascades, and induce both cytokine storms and push an 
individual into a HIP.  
This protocol used M. tuberculosis and M. leprae for the initial exposure not only 
because these lysates represent two closely related prevalent chronic infections, but also 
because these infections are associated with similar biological and social factors in 
humans (Crespo et al. 2017; Roberts 2011). S. aureus was chosen for this experiment in 
part because of its association with periosteal lesions, and the potential compounding 
interaction it could have in the face of prior infection with mycobacterial species. The 
experimental question also applies to P. gingivalis, and this particular pathogen was 
chosen in part for its association with periodontal lesions. Similar observations are made 
for cytokine expression for follow up with Pg following TB or LP as were made with Sa. 
Again, there are also observed differences between the response to the untreated controls 
followed by different pathogens. 
 P. gingivalis elicits a strong host reaction provoking different immune responses 
depending on whether it initially stimulates endothelial or epithelial cells, resulting in 
differing cytokine expressions (Kocgozlu et al. 2009). Interestingly studies have shown 
that only epithelial cells (not endothelial) will secrete IFNγ and TNFα in response to P. 
gingivalis, and this stimulation was associated with periodontal sites of infection 
(Kocgozlu et al. 2009). The variable responses that P. gingivalis exerts from the host may 
also help to explain why as a local, yet chronic, infection it might exert systemic 
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influences (Kocgozlu et al. 2009). Exposure to Pg stimulated cytokine expression in our 
experimental model; exposure to Pg initially, or subsequently, produced increases in 
cytokine expression as compared to the untreated control. However, the patterns of 
expression are quite different from that of Sa, where exposure to Sa tended to elevate 
cytokine expression, and initial exposure to Sa increased cytokine expression across the 
board. Early exposure to Pg did not dampen cytokine expression but did not significantly 
elevate it either. However, with early exposure to LP or TB, then Pg elevated the 
response as compared to similar controls. Clearly P. gingivalis does not operate within 
the host immune response the same way that S. aureus does, and P. gingivalis while 
inflammatory, is not so much to the extent that S. aureus is. However, these preliminary 
results show that there is likely immune modulation occurring with subsequent exposure, 
and P. gingivalis should be considered seriously as a potential candidate for helping to 
push an individual into a HIP.  
The initial results of this first experimental protocol suggest that there is some 
immune alteration that occurs in response to secondary exposure to Pg or to Sa, following 
preliminary exposure of PBMCs to TB and LP. This suggests that chronic infections, 
followed by a secondary infection or insult, may create an environment in which it is 
likely that this second insult could push the individual into a HIP.   
Pre-activation with proinflammatory mediators 
 
The goal of the second experimental protocol was to determine whether PBMCs 
could generate an inflammatory shift and alter their immune responses to pathogens if 
they had been primed with proinflammatory factors. This experiment highlighted broad 
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differences in cytokine expression based on the experimental conditions, specifically the 
influence of the proinflammatory primers. 
 Priming with IFNγ increased cytokine expression, but follow up with a pathogen 
significantly increased it, suggesting that an initial inflammatory environment may 
exacerbate subsequent responses, and may help to push an individual into a HIP, or 
maintain a HIP. Early exposure to TNFα prompted a large increase in TNFα expression 
unsurprisingly, as observed in the initial condition as well as in elevated expression of 
both the Pg and Sa conditions. The robust expression of TNFα may be explained in part 
due to its synergistic relationship with IFNγ, where IFNγ can stimulate and promote 
macrophage production of TNFα, especially in contexts with mycobacterial species (Van 
Crevel et al. 2002). The combinatorial effects of these two cytokines are most noticeable 
together in the context of pathogen exposure. The interplay between cytokines 
themselves provides some context to how an infection or insult could shift an individual 
into a HIP. TNFα is a potent inflammatory cytokine on its own, capable of inducing 
additional cytokine production and activating the innate immune system (Turner et al. 
2014). IFNγ, also proinflammatory on its own, functions to stimulate macrophage 
activation as well as enhance neutrophil and monocyte functions in the innate response 
(Turner et al. 2014). Together these potent cytokines enter a feedback loop, magnifying 
their impact, and creating the setup for potential spillover allowing an initially local event 
to exert a systemic impact. Yet even acting synergistically these cytokines are also 
functioning as part of a diverse array of complex signaling pathways, the regulation of 
which triggers either pro or anti-inflammatory actions. Dysfunction in basic cytokine 
signaling pathways can contribute to inappropriate sustained inflammation, and the 
68 
 
creation or maintenance of a HIP may also be a reflection of such dysfunction (Hanada 
and Yoshimura 2002). It is not only the pathogen that exerts a response, even the 
messengers and mediators of the immune system itself can exert effects on the host 
immune response.  
Of note, exposure to Pg elicited the strongest response in regard to both IFNγ and 
TNFα. One potential explanation is that periodontal diseases tend to elicit a strong 
inflammatory response, recruiting multiple cytokines including IFNγ and TNFα to the 
site of infection. This proinflammatory response not only has consequences in terms of 
potential spillover, but the potential for the development of alveolar resorption, 
something readily identifiable in the osteological record (Cochran 2008). It is also 
interesting to note that while LPS was used as a positive control to definitively prompt an 
inflammatory response in the first two protocols, here it was used as its own condition, 
and did not elicit as strong of reactions as observed from the two cytokines. The response 
that LPS elicits is an alarm to the host and not necessarily in the bacterium’s best interest, 
perhaps explaining in part why the response elicited is not to the same extent as was 
observed with the proinflammatory cytokines, where the job is to mount and sustain an 
effective response to a persistent infection.  
For this protocol, a third cytokine was investigated: interleukin 1 (IL-1). IL-1 is 
now recognized as an entire family of proteins, and this protocol used IL-1β specifically. 
IL-1β is another potent proinflammatory cytokine, expressed by numerous cell types, 
including macrophages, and is also synthesized by multiple immune cells (Turner et al. 
2014). Of particular note here was the general robustness of IL-1β expression observed in 
these experiments, especially for conditions that featured Pg. Manifestations of 
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periodontal disease are heterogenous, just as the various immune responses such disease 
triggers. This heterogeneity explains in part differing periodontal outcomes, ranging 
between stable long term infections that do not present with tissue damage, and highly 
inflammatory conditions with rapid degradation of tissue (Seymour and Gemmell 2001). 
IL-1β is one of the major mediators of tissue destruction associated with bacterial 
periodontal disease. P. gingivalis stimulates macrophages, which in turn are major 
producers of IL-1β. Yet in cases of advanced periodontitis macrophage numbers were not 
observed to be significantly elevated, and P. gingivalis appeared to be eliciting an IL-1β 
response from B cells rather than the expected macrophages (Seymour and Gemmell 
2001). Add in considerations of Th1 and Th2 responses, which if are insufficient, and 
where for example IFNγ production does not adequately address plaque biofilm 
production, the burden of infection control falls again to B cell production, with an 
increasing amount of IL-1β expression and subsequent tissue consequences (Seymour 
and Gemmell 2001). Interestingly, a study conducted using PBMCs stimulated with 
mitogens from periodontitis patients showed reduced IFNγ, which was observed as well 
for the Pg/Pg condition in this protocol, along with significantly elevated IL-1β 
expression over both other cytokines (Sigusch et al. 1998).  
Both P. gingivalis and S. aureus are of interest here not only for their dynamic 
interactions with the host immune system, but for the potential each presents in terms of 
consequences for bone loss. P. gingivalis and periodontal disease encapsulate the 
combination of inflammation and bone physiology so well that it has been noted that it is 
now appropriate to consider these diseases under the purview of the field of 
osteoimmunology, a particularly useful interdisciplinary field that aligns with, and is 
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included in, the four-field model proposed above (Cochran 2008; Crespo 2018). Bone 
resorption does not happen instantaneously with infection; rather resorption depends in 
part on the expression of proinflammatory cytokines, including IL-1β and TNFα. TNFα 
in the context of periodontal disease plays a role in ramping up the inflammatory 
response, as well as upregulating IL-1β, and animals models have shown that those with 
a deficient TNFα receptor exhibited reduced alveolar bone loss (Garlet 2010). The role of 
IFNγ is complicated in the context of periodontal disease. Studies have shown that the 
down regulation of IFNγ acts to inhibit bone resorption (Cochran 2008). In vitro studies 
demonstrate that IFNγ plays a role in inhibiting pathological osteoclastogenesis (the bone 
cells responsible for bone resorption), yet in vivo studies demonstrate that IFNγ 
upregulates TNFα and IL-1β, promoting inflammation and bone resorption (Garlet 2010). 
The contradictory information just highlights the numerous complex potential pathways 
that are balanced on the presence or absence of just a few factors. The destructive effects 
of proinflammatory cytokines, such as the case with TNFα, may reflect the necessity of 
balancing those detrimental inflammatory effects with its role in fighting the bacterial 
infection behind the disease.  
The initial results of this second experimental protocol suggest that there is some 
immune alteration that occurs in response to the pre-activation, or priming, of PBMCs 
prior to secondary exposure to Pg or to Sa. This suggests that chronic infections, or other 
contexts of sustained elevated inflammation, followed by a secondary infection or insult, 
may create an environment in which it is likely that this second insult could push the 
individual into a HIP, or maintain the presence of such.   
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Indirect immune responses 
The third experimental protocol focused on the question of whether immune 
factors released by PBMCs exposed to a pathogenic insult would affect subsequent 
cytokine expression by naïve PBMCs, or PBMCs previously exposed to Sa. That is, 
would those cells that did not have direct access to the pathogen still alter their cytokine 
production? The use of supernatants from conditions with pathogen exposure were used 
to model this secondary influence. In addition, for this protocol we were only able to 
focus on the subsequent reactions to Sa and Sa supernatant. One additional limitation of 
this experiment was limited sample availability, thus the sample size for these 
experimental conditions tended to be smaller than the conditions for the other two 
protocols. 
Clearly, there is some immune alteration occurring based on some of the specific 
responses from exposure to supernatants. Overall, previously unexposed PBMCs did 
exhibit activity based on exposure to supernatants alone on the second day and cytokine 
expression does not appear to decrease with exposure to the supernatants. This indicates 
that it is possible that immune factors can induce expression changes in these naïve cells 
without direct exposure to the provoking insult. Based on visual examination of the data 
(see Figure 15) it is also possible to infer that there are divisions within the conditions 
themselves, with clear divisions between PBMCs that are responders versus those cells 
that are not responsive to the stimuli.  
The triggering of an immune response without direct contact with the insult 
makes sense, as alerting the rest of the immune system helps the body as a whole deal 
with the potential crisis. Cells of the innate immune system traffic to the local lymph 
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nodes where they encounter the cells and mechanisms needed to help ramp up the initial 
immune response as well begin activation of acquired immunity. Cytokines and 
chemokines serve as chemical messengers, and in situations where a strong cytokine 
response results in spillover, this creates a state in which these proinflammatory 
messengers are now no longer contained to the initial site of infection. They can now 
exert a proinflammatory influence on other cells outside the pathway of the lymph nodes 
and traditional activation. There are many different ways in which this might happen, 
ranging from the interaction with byproducts of complement activation to the influence of 
a pre-existing HIP. Further, if such immune activation is possible, and this experimental 
model suggests that it is, logically this effect and the consequences of such could be 
increasingly exaggerated when preconditions, such as chronic infections, are in play. The 
presence of non-responders in the data does not rule out this possibility. Rather it 
highlights the variability inherent in humans. Non-response to an experimental condition, 
or even limited response of one cytokine does not rule out the potential of other 
cytokines, other signaling pathways, or other stimuli to prompt these systemic reactions 
indirectly in vivo.  
This is a good reminder that experimental models have their limits, and while in 
vitro experiments can tease out the nuances of cell behavior, it cannot be conducted in 
isolation. Other fields, and other studies must complement it, as the in vivo reality may 
differ. This is not to argue against these experimental models; they serve as the 
foundation for working out the intricacies of cellular behavior and have elucidated the 
immensely complicated pathways that the immune system utilizes. These experiments 
cannot be an end in of themselves, rather, incorporation of multiple disciplines and 
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perspectives add nuance to interpretation of results, and also highlight areas that need a 
closer look, such as with the discrepancies of IFNγ and periodontal disease. The context 
in which these microscopic pathways play out matters. It is not only the local immediate 
environment at the site of infection or injury that matters. Humans are biosocial creatures, 
and broader context is necessary to better frame what is happening at the cellular level. 
That is, these molecular players can be influenced by situations other than pathogen 
contact or direct bodily injury. The various potential ways in which the immune system 
reacts to pathogens, as well as to its own products, are the starting points and foundation 
for considering ways in which subsequent immune reactions influence the creation or a 
maintenance of HIP.  
Expanding on an experimental foundation  
While the data presented above are strictly experimental, they can be further 
contextualized by both previous work as well as the future potential that this line of 
research may take. The experimental design and protocols here follow that previously 
published by this lab; experimental protocols developed to investigate the potential of 
how exposure to pathogens might generate an inflammatory shift, further affecting the 
immune response against other persistent pathogens (including the Pg investigated here) 
(Crespo et al. 2017). Crespo et al. (2017) found that direct exposure to bacterial lysates 
(TB and LP) induced an inflammatory shift when PBMCs were subsequently exposed to 
Pg. The experiments presented above add on to this initial question, with the addition of 
the S. aureus lysates in addition to Pg, as well as extend it, to question whether early 
exposure to pro-inflammatory mediators might also have an impact as well.  
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The results of this work highlight similar conclusions to that of Crespo et al. 
(2017) in regard to exposure to bacterial lysates followed by subsequent exposure to a 
lysate representing a persistent infection, in that there is a shift in immune response as 
demonstrated by the PBMCs’ cytokine expression. The second question of how this 
might look with early exposure to the proinflammatory mediators themselves (cytokines 
and LPS) adds on to this, showing another route immune modulation may take. In 
addition, the work here suggests that there are nuances in the inflammatory response to 
different pathogens. This is especially relevant as the different model pathogens used, S. 
aureus and P. gingivalis, generally present at different locations, but are both associated 
with generalized bone lesions. Nuanced and tailored responses by the immune system to 
pathogens are not a novel idea, nor is the general underlying framework of these 
experiments novel. The considerations of these cellular reactions within the framework of 
an inflammatory response are of interest for the potential pathological consequences to 
the host, absolutely relying on the groundwork from the field of experimental 
immunology. The questions asked, and the protocols run here, only serve to provide 
further experimental grounding with which to cement how this experimental work is 
relevant to broader systemic questions of inflammation and bone.  
In sickness and in health the immune system functions with great complexity, and 
context matters for any understanding of immune function, especially inflammation. The 
microenvironments of the initial inflammatory response are as important to understanding 
hyperinflammation as much as the external environment and the social and psychological 
well-being of an individual. It is increasingly recognized that other stimuli can trigger 
inflammatory events beyond pathogen exposure and injury. The inflammatory phenotype 
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and immune competence vary from person to person, hence the necessity to consider an 
expanded analysis beyond the immediate inflammatory triggers, especially one that takes 
into account the biosocial context. While the data presented here are strictly 
experimental, the future potential of this line of research must take into consideration a 
comprehensive, more holistic context to frame any broader conclusions.  
The application and extension of questions regarding the role of inflammation and 
consequences of inappropriate manifestations of such into other lines of inquiry, such as 
biosocial and bioarchaeological realms, requires nuance in analysis and context to both 
ground and frame these queries. In trying to understand hyperinflammation, and the 
potential of reconstructing it from bones, it is important to recognize there are multiple 
pathways available to trigger the inflammatory response, some of which will not be as 
immediately obvious as the characteristic lesions made by specific pathogens, or the 
marks of blunt force trauma. Understanding the broader biosocial context of an individual 
may help to frame the observations made upon their skeleton, as well as guide what 
questions can be raised. The experimental protocols outlined above are not a means to an 
end in of themselves. Rather, these experiments are the start of a foundation for a line of 
inquiry that stretches from the experimental to the observational. The development of the 
four-field model (see Figure 1) requires an experimental foundation. However, this 
experimental foundation must be augmented with an expanded biosocial perspective in 
order to be feasible for further applications, such as contributing to the development of a 
skeletal inflammatory index.  
 Stress is an ubiquitous term, but its usage in bioarchaeological models is useful 
here as an understanding of synergistic interactions between the environment, culture, 
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and psychological disruption, which provides a model for understanding alternative 
pathways that might trigger inflammation (Reitsema and McIlvaine 2014). Over the 
course of the 20th century notions of stress have evolved from a pure physiological 
response to stimuli, to a complex and nuanced biobehavioral response which occurs in 
reaction to both biological as well as nonbiological (i.e., socioeconomic; political) stimuli 
(Goodman et al. 1988). Contextual biosocial information is not always available such as 
nutritional status or community support, but these and other factors do play an important 
role in experiences of stress (Reitsema and McIlvaine 2014). It is important not to box in 
the use of stress as a purely typological counterpart to notions of health, but rather to 
utilize it in a more comprehensive manner which further amplifies its potential 
applicability to interdisciplinary studies (Temple and Goodman 2014).  
In regards to inflammation, the immune system responds to both psychological as 
well as psychosocial stressors as evidenced by circulating markers such as 
proinflammatory cytokines (Steptoe et al. 2007). Physiological responses such as 
increased blood pressure in turn have cascading effects, as the physical changes including 
increased hydrostatic pressure force plasma into interstitial spaces, creating new 
opportunities for mediators to interact (Steptoe et al. 2007). This makes sense, as many 
proinflammatory mediators act in concert when in contact with one another. Stress 
hormones generally exert an anti-inflammatory response, but for local responses the 
opposite occurs with an upregulation of pro-inflammatory cytokines (Elenkov and 
Chrousos 2002). Indeed, it is also the case for more typical stressors that if a generalized 
stress response is unable to return the system back to homeostatic normal then an 
inflammatory response can be induced (Chovatiya and Medzhitov 2014). Cytokines 
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themselves have also been implicated in the onset of sickness behavior (i.e., weakness, 
malaise, suppression of appetite), and it stands to reason that in cases of increased 
cytokine activity prompted by another stimulus could also implement sickness behavior 
(Dantzer 2001). That is, when cytokines are interpreted by the brain to implement an 
adaptive program of sickness behavior to preserve resources to fight an infection, it 
triggers certain behavioral responses. All of this to say that stress from nonpathogenic 
stimuli clearly can exert an effect of the body, and inflammation is not restricted to tissue 
injury or control of infection. Stress is one mechanism that accounts for the biological as 
well as the social impact of environment, and the potential mechanism which may help to 
explain the creation or maintenance of a HIP, especially when considering stress as an 
additional factor layered onto underlying injury or infection.  
Stress is a prime example of how to further contextualize and frame experimental 
questions moving towards bioarchaeological and biosocial considerations. Of course the 
challenges of stress are amplified when trying to reconstruct health status in a past 
population, and stress cannot be considered merely the lack of health, reducing both 
constructs to mere typological categories (Temple and Goodman 2014). While the field 
of bioarchaeology has been grappling with stress as well as how to reconstruct and better 
understand health in the past since at least the early 1980s, recent calls have been put 
forth to reevaluate how to better utilize stress (Goodman et al. 1988; Reitsema and 
McIlvaine 2014). However, even before this most recent renewed interest in the 
conceptual problems of stress, researchers had begun to wrangle with the problems 
associated with reconstructing health in the past. Conceptually, researchers took the next 
step and developed a health index; a tool that could account for multiple data points and 
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standardize skeletal measurements to better discuss and interpret results (Steckel et al. 
2002). While this health index was not without some critiques it did account for the 
importance of distinguishing between material and health aspects, as well as the 
underlying importance of context. It is the development of a tool such as the health index 
that allows for some degree of standardization, which ultimately allows analyses to be 
built upon and expanded upon.  
More holistic and encompassing analyses of data that can incorporate local 
histories and archaeological context as well as biology and physiology produce data with 
more depth than just answers of presence or absence for typological categorization (Klaus 
and Tam 2009). The development of indices as tools to better grapple with complex and 
nuanced data also aligns with a more holistic approach to studying stress in skeletal 
remains; one that accounts for both biological responses within physiological as well as 
local biocultural contexts. The development of a skeletal frailty index for example, 
attempts to account for relationships between health and stress from standardized 
indicators of stress already utilized in bioarcheological research to tease out and evaluate 
frailty in past human populations (Marklein et al. 2016). This index which builds upon a 
solid foundation of work in the field allows for a more nuanced interpretation of the same 
skeletal data and allows for a shift in perspective to occur. The frailty index is compelling 
because it addresses a very abstract concept yet is grounded in concrete analyses. 
Immune competence and hyperinflammation are similar, abstract in concept yet also 
material in that the physical cells and mediators exert physical changes. 
It is in this context that the importance of developing and building an 
experimental foundation within a model is especially relevant, as this foundation may 
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help to better develop additional tools, such as the development of a skeletal 
inflammatory index (SINDEX). To get to the point where it possible to utilize something 
like a SINDEX, a solid foundation of experimental and observational data and theory is 
necessary. The experiments laid out here are the start of how such experimental data 
might be generated. These experiments look at specific cells and specific reactions, but 
the potential to consider these immune reactions in broader biosocial context, such as 
placed within analyses of stress, combines multiple perspectives to develop a more 
nuanced conclusion. The great potential of a tool such as SINDEX can only be realized 
because it will be built upon, and it will rely upon, an experimental foundation 
strengthened by multiple contributors (experimental immunology, osteoimmunology, 
archaeoproteomic analysis, and paleopathology), all to be synthesized into a framework 
that provides the structure, and this experimental grounding, to begin reconstructing the 
inflammatory phenotype in the past. 
The broad development of an experimental base upon which to build a model, or 
to begin to construct an index, reflects trends in the development of the field of 
bioarchaeology as well. These trends are calls for critical evaluations of concepts and 
usages that have become standard practice (i.e., health and stress). Reevaluation of what 
has become accepted practice provides opportunity to critically evaluate both the results 
of a study, moving the field beyond set paradigms of what information the osteological 
record does and does not provide. Careful considerations utilizing rubrics and indices are 
necessary for observation and standardized recordings of data, yet a balance must be 
struck between rigor in use of terminology and data collection, and the flexibility to 
adjust these tools when reevaluation is necessary (Klaus 2017; Temple and Goodman 
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2014). These trends in bioarcheology are also calls to advance the field forward, not just 
reevaluations of the past. Indeed, the development of these experimental models are in of 
themselves a response to a call for cross-disciplinary research in order to promote more 
complete understandings of health within the bioarchaeological context (Klaus 2014). 
Factoring in the biocultural perspective is necessary to frame interpretations from 
the bioarchaeological record, as humans are biocultural creatures and our biology and 
physiology should not be investigated in isolation. In the context of disease interaction, of 
relevance here for the potential inflammatory impact of multiple or comorbidities, it is 
becoming apparent that this expanded perspective is necessary to better understand 
experiences of health. This is especially relevant for understanding the varied and 
dynamic factors that contribute to normal inflammation, yet alone the myriad 
complexities that allow for systemic, chronic, and, severely pathological manifestations 
of such. Inflammation is not only the actions of the cytokines and the chemical responses 
to stimuli, but it is also a product of that individual’s own history, their evolutionary 
context, their social, political, and economic standing, and more. The syndemic approach 
should be briefly mentioned here, as it factors in consequences of disease in the context 
of social, economic, and environmental factors, expanding beyond comorbidities as 
simple additive layers of disease, and investigates these disease interactions along the 
lines of multifactorial interactions (Singer et al. 2017). The syndemic approach considers 
the population level clustering of diseases, both biological and social. The complexities 
of disease interactions are better explained in context of the socioeconomic and cultural 
environments. The syndemic approach in conjunction with the reconstructions of 
inflammatory processes in the past creates the potential for a new perspective on health in 
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past populations, by combining the individual inflammatory experiences with 
considerations of population level trends in regard to health and disease.  
  Recognizing the dynamic nature of human biology and that humans are 
biocultural creatures, sets the stage for increasingly synthesized analyses. The potential of 
reconstructing inflammatory phenotypes, of understanding immune competence, is the 
extrapolation of this information, via tools and indices such as the proposed SINDEX, to 
larger frameworks (including the syndemic approach). It is at this intersection where 
these disparate fields come together allowing for the creation of multidisciplinary models, 
whose utilization allows for these advancements in theory and knowledge to take place. It 
is the product of these sorts of intersections that allows for the expansion of the field of 
bioarchaeology and allows for this better integration of fields of study once thought 
removed from the purview of one another. The combinatorial analyses provided by 
disparate fields creates the context in which a more holistic understanding is possible, one 
that captures the nuances of the dynamic interplay between multiple factors. 
 This nuanced approach that incorporates both biology and culture, falls 
completely under the purview of one discipline: anthropology. The anthropological lens, 
and the biocultural synthesis, allows for this approach to immunological and osteological 
perspectives. It is within the anthropological lens that biology and culture can be 
considered together, and not as mere dialectical opponents. It is the extrapolation and 
expansion of the realm of analysis, and the additive totals that allow for the development 
of something such as analysis of health in the past, which attempt to provide additional 
perspective to old bones. Moving beyond a biocultural synthesis, incorporating culture 
into human biology, and both again back into anthropology, creates these advancements 
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in what is possible and what potential information may be gleaned from such 
combinatorial efforts (Goodman 2013).  
 This synthesis is not an abandonment of what each individual field has to offer, or 
the core tenants of each. Day to day osteological analysis must still rely on anatomical 
and terminological rigor. The field of bioarcheology must rely on the establishing 
principles and guidance of researchers past, just as immunologists in the lab must still 
follow the established protocols that allow cells to live in a petri dish long enough to 
survive for chemical analysis. The anthropological lens permits the combination of the 
insights from multidisciplinary collaboration into a new synthesis of results and analyses, 
while retaining (and refining) the underlying methodologies and tools of data collection. 
Pursuing inflammation in the past, via reconstructions of potential immune competence 
and the search for a hyper-inflammatory phenotype embody the anthropological method 
well. Here then lies the potential to better understand the available evidence from the 
human biological past, a starting point for the potential to investigate mechanisms of 
health in life (immune competence; inflammatory phenotypes) in those long since passed. 
Yet the potential of these broad analyses will always fall back on the foundation holding 
them up. For investigations of health in the past experimental work will continue to 
provide this foundation. For considerations of inflammation in the past, only hinted at in 
the bone, experimental methods building one on top of the other (osteoimmunology on 
top of experimental immunology, and archaeoproteomics on top of both and so on), will 
create the platform for this analysis, and the potential reconstructions, one piece of the 
puzzle at a time.  
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Limitations & Pitfalls 
 As with any study there will be limitations and potential pitfalls. No experimental 
design is perfect, and in regard to experimental immunology certain inherent dilemmas 
must be dealt with. For the experimental models used here, these are understood to be 
limited models based on specific cells reactions in vitro. These models do not reflect the 
complexity of the immune system functioning in vivo, and all interpretations of such are 
framed and limited by the applicability of these isolated results to the whole.  
 In regard to the cells utilized, peripheral whole blood mononuclear cells (PBMCs) 
are not truly naïve immune cells, even though they are treated as such for the 
experimental conditions. Truly naïve immune cells will not be found in circulation and 
must be taken directly from germinal centers such as the spleen, something possible only 
in animal models. Our PBMCs came from healthy donors’ bloodstreams, so while in 
theory these were not actively fighting infection, they are not naïve. However, it is 
accepted that one of the better ways of assessing peripheral cytokine function is to study 
the ability of PBMCs to produce cytokines when placed in culture and stimulated, so 
there is some debate still about this practice (Dantzer 2001). 
 For the statistical analyses, interpolated values were used for values that were 
above the plate readers limit of upper detection. Ideally those samples would have been 
rerun at dilution and then the results multiplied by the dilution factor in order to capture 
those larger values. Constraints on laboratory funding, sample availability, and time did 
not allow for dilutions to be run. One well from a plate provided a little under 1ml of 
supernatant, to be divided into two, sometimes three aliquots for analysis, and in some 
cases not enough supernatant was available for reruns or dilutions.  
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 As discussed, the immune system is complex and varied. Inflammatory responses 
may be triggered by a multitude of factors. One such factor is seasonality, in which 
inflammation varies by season (Ashley et al. 2012). Louisville, Kentucky does experience 
all four seasons, and the timing of when future experiments are run to account for 
potential seasonal variability might be taken into consideration, but the realities of when 
funding for said experiments is available and when there is time to run experiments 
cannot be dismissed either.   
 In broader discussions of placing inflammation in context, multiple perspectives 
lie well beyond the scope of this thesis. Neuroendocrine regulation and related pathways 
are one such area that warrants a closer look. For the goal of a broad baseline of basic 
context to inflammation, this thesis focused briefly on homeostasis in regard to 
contextualizing mechanisms of inflammation and placing inflammation in an 
evolutionary context. However, it is increasingly recognized that homeostasis may not be 
the most appropriate phenomenon to understand stress and inflammation, and not taking 
into further consideration the role of allostasis and disruption of allostatic loads is one 





 Pursuing experimental work of any type is an undertaking requiring multiple steps 
and considerations. The objective of this thesis was to provide some experimental 
evidence to contribute to the proposed multidisciplinary reconstruction of inflammatory 
phenotypes in skeletal samples. More specifically this thesis questioned whether if in 
vitro priming of immune cells could generate an inflammatory shift, altering the immune 
response to pathogens (exposure to bacterial lysates) commonly associated with 
persistent infections such as those associated with periodontal disease and periosteal 
lesions. 
 Broadly, these three experimental protocols do show that there is some immune 
modulation occurring in response to exposure to bacterial lysates or other 
proinflammatory stimuli. Even with the limitations of in vitro extrapolation, these results 
are of interest as they are the first step hinting at potential pathways and mechanisms that 
would create these inflammatory environments in which exacerbation of lesion formation 
may occur. The results of the first experimental protocol indicate that some immune 
modulation does occur in PBMCs initially exposed to bacterial lysates (TB; LP) and 
sequentially exposed to additional lysates (Pg; Sa), that represent common, persistent 
infections. The second protocol also showed that priming of naïve PBMCs with 
proinflammatory mediators also produces a change in PBMCs’ cytokine expression 
following subsequent exposure to bacterial lysates (Pg; Sa). Finally, the third protocol 
showed that immune modulation is also likely occurring in response to indirect 
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stimulation from the byproducts of other PBMCs, which had previously been exposed to 
bacterial lysates.  
 What these experimental protocols together suggest is that stimulation, direct or 
indirect, and compounded with sequential exposure, does produce a shift in the 
inflammatory response of these cells. This suggests several pathways in which an 
inflammatory environment might be created or maintained, with this implication that 
these inflammatory environments may also play a role in the creation or maintenance of 
an individual’s hyper-inflammatory phenotype. Of particular interest are the differences 
in cellular response to the varied lysates, particular Pg and Sa. The dynamic nature of the 
pathogens represented in these experiments and the preliminary experimental results are 
of particular interest given their association with certain (non)specific osteological 
lesions. There is great potential for future osteopathological reconstructions to consider 
the role of the pathogen at play, as well as considerations for the overall role of 
inflammation and an individual’s inflammatory phenotype.  
 Finally, this inflammatory context is of great importance for teasing out nuances 
in health, past and present, and the causes and mechanisms of inflammation are an 
important background for these considerations. The foundation for all analysis here, and 
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1. Cell Culture Template 
 
SINDEX (Systemic Inflammatory InDEX) 
Sample or Experiment #:                                                          Date: 
Cells:                                                                                           
 
1) Cell collection following Protocol # 1 for Day 1 and Day 2 (in binder) 
 
2) Experimental conditions for Day 1 and Day 2: 
 
     Final volume/well:                                                                   Cells (total count/initial):  
     Cells/ml: 
 
      LPS [stock]:                          - Added to well:   
      IFNγ [stock]:                         - Added to well:       
      TNFα [stock]:                        - Added to well:   
      P. gingivalis [stock]:              - Added to well:   
      S. aureus [stock]:                   - Added to well:                 












24 hrs 48hrs 
1 UNT UNT 
2 Pg Pg 
3 LPS Pg 
4 IFNγ Pg 
5 TNFα Pg 
6 Sa Sa 
7 LPS Sa 
8 IFNγ Sa 
9 TNFα Sa 
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2.  ELISA Template  
 
Example of ELISA notetaking form to help organize ELISA plates  
                                                                                     
Project:  
Date:                                                                                   
Personnel: 
Cytokine/Protein:  






























 NC NC ST7 ST7         
B 
 BLK BLK ST8 ST8         
C 
 ST1 ST1           
D 
 ST2 ST2           
E 
 ST3 ST3           
F 
 ST4 ST4           
G 
 ST5 ST5           
H 
 ST6 ST6           
 
 
Sample Dilution: None 
Sample diluent: None 
Standard diluent: eBioscience Assay Diluent 











Adjusted P values TNFα – S. aureus 
Dunn's multiple 
comparisons test Adjusted P Value 
Dunn's multiple 
comparisons test Adjusted P Value 
UNT vs. UNT/UNT >0.9999 TB/UNT vs. TB/TB 0.5656 
UNT vs. UNT/TB 0.0514 TB/UNT vs. TB/LP 0.5161 
UNT vs. UNT/LP 0.005 TB/UNT vs. TB/Sa 0.0003 
UNT vs. UNT/Sa <0.0001 TB/TB vs. TB/LP >0.9999 
UNT/UNT vs. UNT/TB 0.1432 TB/TB vs. TB/Sa 0.0654 
UNT/UNT vs. UNT/LP 0.0165 TB/LP vs. TB/Sa 0.1669 
UNT/UNT vs. UNT/Sa <0.0001 LP vs. LP/UNT 0.0001 
UNT/TB vs. UNT/LP >0.9999 LP vs. LP/TB >0.9999 
UNT/TB vs. UNT/Sa 0.3306 LP vs. LP/LP 0.1377 
UNT/LP vs. UNT/Sa >0.9999 LP vs. LP/Sa 0.3736 
TB vs. TB/UNT 0.0003 LP/UNT vs. LP/TB 0.0017 
TB vs. TB/TB 0.2353 LP/UNT vs. LP/LP 0.4082 
TB vs. TB/LP 0.6548 LP/UNT vs. LP/Sa <0.0001 




Dunn's multiple comparisons test Adjusted P Value 
LP/TB vs. LP/Sa >0.9999 
LP/LP vs. LP/Sa 0.0009 
Sa vs. Sa/UNT >0.9999 
Sa vs. Sa/TB >0.9999 
Sa vs. Sa/LP >0.9999 
Sa vs. Sa/Sa >0.9999 
Sa/UNT vs. Sa/TB >0.9999 
Sa/UNT vs. Sa/LP >0.9999 
Sa/UNT vs. Sa/Sa >0.9999 
Sa/TB vs. Sa/LP >0.9999 
Sa/TB vs. Sa/Sa >0.9999 
Sa/LP vs. Sa/Sa >0.9999 
UNT/Sa vs. TB/Sa 0.7541 
UNT/Sa vs. LP/Sa >0.9999 
UNT/Sa vs. Sa/Sa 0.3005 
TB/Sa vs. LP/Sa >0.9999 
TB/Sa vs. Sa/Sa >0.9999 
LP/Sa vs. Sa/Sa >0.9999 
 
Adjusted P values IFNγ – S. aureus 
 
Dunn's multiple comparisons 





UNT vs. UNT/UNT >0.9999 TB/UNT vs. TB/Sa 0.0007 
UNT vs. UNT/TB 0.0035 TB/TB vs. TB/LP >0.9999 
UNT vs. UNT/LP 0.2244 TB/TB vs. TB/Sa 0.0135 
UNT vs. UNT/Sa <0.0001 TB/LP vs. TB/Sa 0.0007 
UNT/UNT vs. UNT/TB 0.0116 LP vs. LP/UNT >0.9999 
UNT/UNT vs. UNT/LP 0.5286 LP vs. LP/TB 0.9669 
UNT/UNT vs. UNT/Sa <0.0001 LP vs. LP/LP >0.9999 
UNT/TB vs. UNT/LP >0.9999 LP vs. LP/Sa <0.0001 
UNT/TB vs. UNT/Sa 0.9752 LP/UNT vs. LP/TB 0.0795 
UNT/LP vs. UNT/Sa 0.0521 LP/UNT vs. LP/LP 0.9363 
TB vs. TB/UNT >0.9999 LP/UNT vs. LP/Sa <0.0001 
TB vs. TB/TB 0.52 LP/TB vs. LP/LP >0.9999 
TB vs. TB/LP >0.9999 LP/TB vs. LP/Sa 0.1422 
TB vs. TB/Sa <0.0001 LP/LP vs. LP/Sa 0.0003 
TB/UNT vs. TB/TB >0.9999 Sa vs. Sa/UNT 0.9051 
TB/UNT vs. TB/LP >0.9999 Sa vs. Sa/TB 0.3737 
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Dunn's multiple comparisons 
test Adjusted P Value 
Sa vs. Sa/Sa >0.9999 
Sa/UNT vs. Sa/TB >0.9999 
Sa/UNT vs. Sa/LP >0.9999 
Sa/UNT vs. Sa/Sa >0.9999 
Sa/TB vs. Sa/LP >0.9999 
Sa/TB vs. Sa/Sa >0.9999 
Sa/LP vs. Sa/Sa >0.9999 
UNT/Sa vs. TB/Sa >0.9999 
UNT/Sa vs. LP/Sa >0.9999 
UNT/Sa vs. Sa/Sa >0.9999 
TB/Sa vs. LP/Sa >0.9999 
TB/Sa vs. Sa/Sa >0.9999 







Adjusted P values TNFα – P. gingivalis  
 
Dunn's multiple 






UNT vs. UNT/UNT >0.9999 LP/UNT vs. LP/LP 0.3535 
UNT vs. UNT/TB 0.0711 LP/UNT vs. LP/Pg <0.0001 
UNT vs. UNT/LP 0.0085 LP/TB vs. LP/LP 0.2054 
UNT vs. UNT/Pg  <0.0001 LP/TB vs. LP/Pg >0.9999 
UNT/UNT vs. UNT/TB 0.1947 LP/LP vs. LP/Pg 0.0167 
UNT/UNT vs. UNT/LP 0.0273 Pg vs. Pg/UNT <0.0001 
UNT/UNT vs. UNT/Pg <0.0001 Pg vs. Pg/TB 0.0002 
UNT/TB vs. UNT/LP >0.9999 Pg vs. Pg/LP 0.0002 
UNT/TB vs. UNT/Pg 0.0584 Pg vs. Pg/Pg <0.0001 
UNT/LP vs. UNT/Pg 0.2907 Pg/UNT vs. Pg/TB >0.9999 
TB vs. TB/UNT 0.0001 Pg/UNT vs. Pg/LP >0.9999 
TB vs. TB/TB 0.1708 Pg/UNT vs. Pg/Pg 0.4163 
TB vs. TB/LP 0.525 Pg/TB vs. Pg/LP >0.9999 
TB vs. TB/Pg >0.9999 Pg/TB vs. Pg/Pg >0.9999 
TB/UNT vs. TB/TB 0.4697 Pg/LP vs. Pg/Pg >0.9999 
TB/UNT vs. TB/LP 0.4227 UNT/Pg vs. TB/Pg 0.0008 
TB/UNT vs. TB/Pg 0.018 UNT/Pg vs. LP/Pg 0.0388 
TB/TB vs. TB/LP >0.9999 UNT/Pg vs. Pg/Pg <0.0001 
TB/TB vs. TB/Pg >0.9999 TB/Pg vs. LP/Pg >0.9999 
TB/LP vs. TB/Pg >0.9999 TB/Pg vs. Pg/Pg >0.9999 
LP vs. LP/UNT <0.0001 LP/Pg vs. Pg/Pg 0.5901 
LP vs. LP/TB >0.9999 
LP vs. LP/LP 0.1095 
LP vs. LP/Pg >0.9999 
 
 










UNT vs. UNT/UNT >0.9999 UNT/UNT vs. UNT/Pg <0.0001 
UNT vs. UNT/TB 0.003 UNT/TB vs. UNT/LP >0.9999 
UNT vs. UNT/LP 0.1654 UNT/TB vs. UNT/Pg >0.9999 
UNT vs. UNT/Pg <0.0001 UNT/LP vs. UNT/Pg 0.6719 
UNT/UNT vs. UNT/TB 0.0112 TB vs. TB/UNT >0.9999 





Dunn's multiple comparisons 
test Adjusted P Value 
Dunn's multiple 
comparisons test Adjusted P Value 
TB vs. TB/Pg 0.0236 Pg vs. Pg/UNT >0.9999 
TB/UNT vs. TB/TB >0.9999 Pg vs. Pg/TB >0.9999 
TB/UNT vs. TB/LP >0.9999 Pg vs. Pg/LP >0.9999 
TB/UNT vs. TB/Pg 0.258 Pg vs. Pg/Pg 0.0216 
TB/TB vs. TB/LP >0.9999 Pg/UNT vs. Pg/TB >0.9999 
TB/TB vs. TB/Pg >0.9999 Pg/UNT vs. Pg/LP >0.9999 
TB/LP vs. TB/Pg 0.217 Pg/UNT vs. Pg/Pg >0.9999 
LP vs. LP/UNT >0.9999 Pg/TB vs. Pg/LP >0.9999 
LP vs. LP/TB 0.8453 Pg/TB vs. Pg/Pg >0.9999 
LP vs. LP/LP >0.9999 Pg/LP vs. Pg/Pg 0.2723 
LP vs. LP/Pg 0.1409 UNT/Pg vs. TB/Pg >0.9999 
LP/UNT vs. LP/TB 0.0537 UNT/Pg vs. LP/Pg >0.9999 
LP/UNT vs. LP/LP 0.7812 UNT/Pg vs. Pg/Pg 0.2364 
LP/UNT vs. LP/Pg 0.007 TB/Pg vs. LP/Pg >0.9999 
LP/TB vs. LP/LP >0.9999 TB/Pg vs. Pg/Pg 0.0414 
LP/TB vs. LP/Pg >0.9999 LP/Pg vs. Pg/Pg 0.5065 































Adjusted P values TNFα 
 








UNT vs. UNT/UNT >0.9999 LPS/Pg vs. LPS/Sa >0.9999 
UNT vs. UNT/Pg <0.0001 TNFα vs. TNFα/UNT 0.0002 
UNT vs. UNT/Sa <0.0001 TNFα vs. TNFα/Pg 0.7501 
UNT/UNT vs. UNT/Pg <0.0001 TNFα vs. TNFα/Sa 0.0535 
UNT/UNT vs. UNT/Sa <0.0001 TNFα/UNT vs. TNFα/Pg 0.0274 
UNT/Pg vs. UNT/Sa >0.9999 TNFα/UNT vs. TNFα/Sa 0.3691 
LPS vs. LPS/LPS 0.0228 TNFα/Pg vs. TNFα/Sa >0.9999 
LPS vs. LPS/Pg 0.9006 IFNγ vs. IFNγ/UNT >0.9999 
LPS vs. LPS/Sa 0.6355 IFNγ vs. IFNγ/Pg 0.0007 
LPS/LPS vs. LPS/Pg 0.8049 IFNγ vs. IFNγ/Sa 0.0109 






IFNγ/UNT vs. IFNγ/Sa 0.0207 
IFNγ/Pg vs. IFNγ/Sa >0.9999 
Pg vs. Pg/UNT <0.0001 
Pg vs. Pg/Pg <0.0001 
Pg/UNT vs. Pg/Pg 0.1934 
Sa vs. Sa/UNT >0.9999 
Sa vs. Sa/Sa >0.9999 
Sa/UNT vs. Sa/Sa >0.9999 
LPS/Pg vs. TNFα/Pg 0.1798 
LPS/Pg vs. IFNγ/Pg 0.0163 
LPS/Pg vs. Pg/Pg >0.9999 
TNFα/Pg vs. IFNγ/Pg >0.9999 
TNFα/Pg vs. Pg/Pg 0.0011 
IFNγ/Pg vs. Pg/Pg <0.0001 
LPS/Sa vs. TNFα/Sa >0.9999 
LPS/Sa vs. IFNγ/Sa 0.1242 
LPS/Sa vs. Sa/Sa >0.9999 
TNFα/Sa vs. IFNγ/Sa >0.9999 
TNFα/Sa vs. Sa/Sa >0.9999 
IFNγ/Sa vs. Sa/Sa 0.2878 
 
Adjusted P values IFNγ 








UNT vs. UNT/UNT >0.9999 IFNγ/UNT vs. IFNγ/Pg 0.0531 
UNT vs. UNT/Pg <0.0001 IFNγ/UNT vs. IFNγ/Sa 0.3179 
UNT vs. UNT/Sa <0.0001 IFNγ/Pg vs. IFNγ/Sa >0.9999 
UNT/UNT vs. UNT/Pg <0.0001 Pg vs. Pg/UNT 0.6754 
UNT/UNT vs. UNT/Sa <0.0001 Pg vs. Pg/Pg 0.0156 
UNT/Pg vs. UNT/Sa >0.9999 Pg/UNT vs. Pg/Pg 0.9877 
LPS vs. LPS/LPS 0.0005 Sa vs. Sa/UNT 0.2327 
LPS vs. LPS/Pg 0.094 Sa vs. Sa/Sa 0.7335 
LPS vs. LPS/Sa 0.248 Sa/UNT vs. Sa/Sa >0.9999 
LPS/LPS vs. LPS/Pg 0.4957 LPS/Pg vs. TNFα/Pg >0.9999 
LPS/LPS vs. LPS/Sa 0.202 LPS/Pg vs. IFNγ/Pg 0.0991 
LPS/Pg vs. LPS/Sa >0.9999 LPS/Pg vs. Pg/Pg >0.9999 
TNFα vs. TNFα/UNT 0.9499 TNFα/Pg vs. IFNγ/Pg 0.1663  
TNFα vs. TNFα/Pg 0.3986 TNFα/Pg vs. Pg/Pg >0.9999 
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TNFα vs. TNFα/Sa 0.3711 IFNγ/Pg vs. Pg/Pg 0.0268 
TNFα/UNT vs. TNFα/Pg 0.0136 LPS/Sa vs. TNFα/Sa >0.9999 
TNFα/UNT vs. TNFα/Sa 0.0124 LPS/Sa vs. IFNγ/Sa >0.9999 
TNFα/Pg vs. TNFα/Sa >0.9999 LPS/Sa vs. Sa/Sa 0.0807 
IFNγ vs. IFNγ/UNT 0.9792 TNFα/Sa vs. IFNγ/Sa >0.9999 
IFNγ vs. IFNγ/Pg >0.9999 TNFα/Sa vs. Sa/Sa 0.0875 




Adjusted P values IL-1 
 
Dunn's multiple comparisons test Adjusted P Value Dunn's multiple comparisons test Adjusted P Value 
Pg/Pg vs. LPS/Pg >0.9999 Sa/Sa vs. IFNγ/Sa >0.9999 
Pg/Pg vs. IFNγ/Pg >0.9999 LPS/Sa vs. TNFα/Sa 0.2443 
Pg/Pg vs. TNFα/Pg >0.9999 LPS/Sa vs. IFNγ/Sa 0.0112 
LPS/Pg vs. IFNγ/Pg >0.9999 TNFα/Sa vs. IFNγ/Sa >0.9999 
LPS/Pg vs. TNFα/Pg >0.9999 LPS/Sa vs. LPS/Pg 0.9452 
IFNγ/Pg vs. TNFα/Pg >0.9999 IFNγ /Sa vs. IFNγ/Pg 0.0317 
Sa/Sa vs. LPS/Sa 0.0986 TNFα/Sa vs. TNFα/Pg 0.2465 






Adjusted P values cross cytokine comparison  
Dunn's multiple comparisons test Adjusted P Value 
TNFα Pg/Pg vs. IL1 Pg/Pg 0.0037 
TNFα Pg/Pg vs. IFNγ Pg/Pg 0.781 
IL1 Pg/Pg vs. IFNγ Pg/Pg 0.0002 
IL1LPS/Pg vs. TNFα LPS/Pg 0.4189 
IL1LPS/Pg vs. LPS/Pg 0.0042 
TNFα LPS/Pg vs. LPS/Pg 0.1218 
IL1 IFNγ /Pg vs. TNFα IFNγ /Pg 0.4299 
IL1 IFNγ /Pg vs. IFNγ IFNγ /Pg >0.9999 
TNFα IFNγ /Pg vs. IFNγ IFNγ /Pg 0.0225 
IL1 TNFα /Pg vs. TNFα TNFα /Pg >0.9999 
IL1 TNFα /Pg vs. IFNγ TNFα /Pg 0.0361 
TNFα TNFα /Pg vs. IFNγ TNFα /Pg 0.0046 
IL1Sa/Sa vs. TNFα Sa/Sa >0.9999 
IL1Sa/Sa vs. IFNγ Sa/Sa 0.5415 
TNFα Sa/Sa vs. IFNγ Sa/Sa 0.6938 
IL1LPS/Sa vs. TNFα LPS/Sa 0.0339 
IL1LPS/Sa vs. IFNγ LPS/Sa 0.0009 
TNFα LPS/Sa vs. IFNγ LPS/Sa 0.626 
IL1 TNFα /Sa vs. TNFα TNFα /Sa 0.5426 
IL1 TNFα /Sa vs. IFNγ TNFα /Sa >0.9999 
TNFα TNFα /Sa vs. IFNγ TNFα /Sa 0.0787 
IL1 IFNγ /Sa vs. TNFα IFNγ /Sa 0.022 
IL1 IFNγ /Sa vs. IFNγ IFNγ /Sa 0.3713 


















5. Protocol 3 Results & Adjusted P values  
 
 
Protocol 3 Adjusted P values TNFα  
 
Dunn's multiple comparisons test Adjusted P Value Dunn's multiple comparisons test Adjusted P Value 
UNT vs. UNT/UNT >0.9999 TB/TB vs. LP/TB 0.927 
UNT vs. UNT/TB 0.1512 TB/TB vs. Sa/TB 0.1624 
UNT vs. UNT/LP >0.9999 LP/TB vs. Sa/TB 0.7918 
UNT/UNT vs. UNT/TB 0.0017 LP/LP vs. TB/LP 0.9942 
UNT/UNT vs. UNT/LP 0.1644 LP/LP vs. Sa/LP >0.9999 
UNT/TB vs. UNT/LP >0.9999 TB/LP vs. Sa/LP >0.9999 
TB/UNT vs. TB/TB 0.0367 LP/Sa vs. TB/Sa >0.9999 
TB/UNT vs. TB/LP 0.864 LP/Sa vs. Sa/Sasp >0.9999 
TB/UNT vs. TB/Sa 0.1704 LP/Sa vs. Sa/Sa >0.9999 
TB/TB vs. TB/LP >0.9999 TB/Sa vs. Sa/Sasp >0.9999 
TB/TB vs. TB/Sa >0.9999 TB/Sa vs. Sa/Sa >0.9999 
TB/LP vs. TB/Sa >0.9999 Sa/Sasp vs. Sa/Sa 0.8938 
LP/UNT vs. LP/SA 0.0299 LP/Sa vs. LP/LP >0.9999 
LP/UNT vs. LP/LP 0.5471 LP/Sa vs. LP/TB >0.9999 
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LP/Unt vs. LP/TB 0.0419 LP/LP vs. LP/TB >0.9999 
 
Sa vs. Sa/TB 0.8543 
Sa vs. Sa/LP >0.9999 
Sa vs. Sa/Sasp >0.9999 
Sa vs. Sa/Sa >0.9999 
Sa/TB vs. Sa/LP >0.9999 
Sa/TB vs. Sa/Sasp 0.7092 
Sa/TB vs. Sa/Sa >0.9999 
Sa/LP vs. Sa/Sasp >0.9999 
Sa/LP vs. Sa/Sa >0.9999 




Adjusted P values IFNγ  
 
Dunn's multiple comparisons test Adjusted P Value 
Dunn's multiple 
comparisons test Adjusted P Value 
UNT vs. UNT/UNT >0.9999 LP/TB vs. TB/TB >0.9999 
UNT vs. UNT/TB 0.0081 LP/TB vs. Sa/TB 0.4368 
UNT vs. UNT/LP 0.0776 TB/TB vs. Sa/TB >0.9999 
UNT/UNT vs. UNT/TB 0.3182 LP/LP vs. TB/LP >0.9999 
UNT/UNT vs. UNT/LP >0.9999 LP/LP vs. Sa/LP >0.9999 
UNT/TB vs. UNT/LP >0.9999 TB/LP vs. Sa/LP >0.9999 
TB/UNT vs. TB/TB >0.9999 LP/Sa vs. TB/Sa >0.9999 
TB/UNT vs. TB/LP >0.9999 LP/Sa vs. Sa/Sasp >0.9999 
TB/UNT vs. TB/Sa >0.9999 LP/Sa vs. Sa/Sa >0.9999 
TB/TB vs. TB/LP >0.9999 TB/Sa vs. Sa/Sasp >0.9999 
TB/TB vs. TB/Sa >0.9999 TB/Sa vs. Sa/Sa >0.9999 
TB/LP vs. TB/Sa >0.9999 Sa/Sasp vs. Sa/Sa >0.9999 
LP/UNT vs. LP/Sa >0.9999 Sa vs. Sa/Sa >0.9999 
LP/UNT vs. LP/LP >0.9999 Sa vs. Sa/Sasp >0.9999 
LP/UNT vs. LP/TB 0.4993 Sa/TB vs. Sa/LP >0.9999 
LP/Sa vs. LP/LP >0.9999 Sa/TB vs. Sa/Sasp >0.9999 
LP/Sa vs. LP/TB >0.9999 Sa/TB vs. Sa/Sa >0.9999 
LP/LP vs. LP/TB >0.9999 Sa/LP vs. Sa/Sasp >0.9999 
Sa vs. SA/TB >0.9999 Sa/LP vs. Sa/Sa >0.9999 




6. Sample Sizes  
 
Total initial sample sizes are reported here. Experimental conditions with less than a 
minimum of four were automatically excluded from analysis. These sample sizes do not 
account for the removal of outliers.  
 
  TNFα (n) IFNγ (n)   TNFα (n) IFNγ (n) 
UNT 31 30 Pg/Pg 22 23 
LPS 15 14 Pg/UNT 11 11 
TNFα 12 12 Pg/TB 8 8 
IFNγ 10 10 Pg/LP 8 8 
Pg 29 29 Sa/UNT 8 7 
Sa 26 25 Sa/Sa 20 19 
TB 36 36 Sa/TB 8 7 
LP 38 36 Sa/LP 8 7 
UNT 37 36 TB/UNT 30 26 
LPS/LPS 8 7 TB/PG 14 14 
UNT/TNFα 2 2 TB/SA 14 13 
UNT/IFNγ 2 2 TB/TB 32 28 
UNT/Pg 17 17 TB/LP 22 21 
UNT/Sa 16 15 LP/LP 38 35 
UNT/TB 13 12 LP/UNT 29 27 
UNT/LP 13 12 LP/PG 12 12 
LPS/Pg 11 11 LP/SA 14 13 
LPS/Sa 12 12 LP/TB 16 15 
TNFα/UNT 8 8 IFNγ/UNT 8 8 
TNFα/Pg 12 12 IFNγ/Pg 10 10 




UNT 7 IFNγ/Pg 5 
UNT/TNFα 2 TNFα/Pg 7 
TNF/U 3 Sa/Sa 7 
UNT/IFNγ 2 LPS/Sa 7 
IFNγ/U 3 TNFα/Sa 7 
Pg/Pg 7 IFNγ/Sa  5 







 TNFα SP (n) IFNγ SP (n) 
UNT 5 7 
LPS 5 4 
Sa 5 4 
UNT/UNT 8 4 
LPS/LPS 5 4 
UNT/TB 5 5 
UNT/LP 5 5 
LP/UNT 7 8 
LP/Sa 5 4 
LP/LP 8 8 
LP/TB 7 8 
TB/UNT 5 5 
TB/TB 4 5 
TB/LP 5 5 
TB/Sa 5 4 
Sa/TB 5 4 
Sa/LP 5 4 
Sa/Sasp 5 4 
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